Volume 9; Issue supp-S5

Main
European Neuropsychopharmacology
Volume 9; Issue supp-S5

European Neuropsychopharmacology

Volume 9; Issue supp-S5

1

Neuropeptide signalling in the CNS: Increasing evidence for a role in psychiatric and neurodegenerative diseases

T. Hökfelt, C. Broberger, M. Diez, J. Koistinaho, K. Kahn, D. Games

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 301 KB

english, 1999

2

New vistas in OCD

J. Zohar, Y. Sasson, M. Chopra

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 136 KB

english, 1999

3

Definitions of response: “Typical” and “atypical” agents in treatment-resistant and partially responsive schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 158 KB

english, 1999

4

Comparing responses to ‘typical’ and ‘atypical’ antipsychotic drugs in schizophrenia: A multidimensional perspective

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 347 KB

english, 1999

5

Can the atypical antipsychotics improve the cost-effectiveness of schizophrenia care?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 378 KB

english, 1999

6

Can negative symptoms of schizophrenia be partially or totally controlled by antipsychotics?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 361 KB

english, 1999

7

The long-term treatment of schizophrenia and prevention of relapse

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 177 KB

english, 1999

8

The biology of placebo; implication of endogenous opioids

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 338 KB

english, 1999

9

Do primary care physicians use antidepressants as placebos?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

10

Placebo controlled trials in depression: Bridging ethics and science

S.H. Kennedy, R.M. Bagby, S.M. McCann, S. Dickens, J. Raskin

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

11

A placebo-controlled trial of igmesine in the treatment of major depression

A.C. Pande, J. Genève, B. Scherrer, F. Smith, R.A. Leadbetter, C. de Meynard

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 162 KB

english, 1999

12

CRH receptor antagonists in mood disorders: Current status

A.W. Zobel, F. Holsboer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 341 KB

english, 1999

13

Orphanin-FQ: Role as a neuromodulator of mood/anxiety-like states in rodents

F. Jenck, J.-L. Moreau, E. Borroni, M. Pauly-Evers, R. Reinscheid, H.-P. Nothacker, O. Civelli, G. Kilpatrick

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 356 KB

english, 1999

14

Central amyloidosis in Alzheimer's disease: Biology of the production of the amyloid peptide

T. Hartmann, M. Simons, M. Jensen, S. Lichtenthaler, C. Bergmann, P. Jäkälä, H. Grimm, D. Zhang, K. Beyreuther

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 361 KB

english, 1999

15

Reactive oxygen species in Alzheimer's disease

C. Behl, B. Moosmann, S. Heck

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 353 KB

english, 1999

16

Neurobiology of Alzheimer's disease: Diagnosis and targets for therapy

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

17

Lazabemide for the long-term treatment of Alzheimer's disease

G. Magni, R.C. Meibach

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

18

Anxiety, mood, and substance abuse disorders: Patterns and correlates of comorbidity

R.C. Kessler, H.-U. Wittchen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 520 KB

english, 1999

19

Anxiety versus depression in animal models

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 175 KB

english, 1999

20

Perimenstrual symptoms in the community: Prevalence, stability, comorbidity

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 343 KB

english, 1999

21

PMS versus PMDD: Diagnosis and classification

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 171 KB

english, 1999

22

Somatic and psychic symptoms of PMD

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 347 KB

english, 1999

23

Why are serotonin reuptake inhibitors effective for the treatment of premenstrual dysphoria?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 360 KB

english, 1999

24

Serotonergic receptore and alcohol dependence

J. De Vry, S. Maurel, R. Schreiber

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 358 KB

english, 1999

25

PET and SPECT studies in alcohol dependence

A. Lingford-Hughes

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

26

Controversial issues in the assessment of craving and its role in clinical trials

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 356 KB

english, 1999

27

Characteristics of responders and non-respondere to acamprosate treatment

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 351 KB

english, 1999

28

New findings concerning naltrexone treatment of alcoholism

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

29

Pharmacological models predicting antipsychotic actions — what is their future use?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 346 KB

english, 1999

30

Models mimicking neurodevelopmental aspects of schizophrenia

G. Wolterink, E.W.P.M. Daenen, M.A.F.M. Gerrits, C.G. Kruse, J.A.M. Van Der Heijden, J.M. Van Ree

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 347 KB

english, 1999

31

Prepulse Inhibition as a model predicting new antipsychotics

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 352 KB

english, 1999

32

Latent Inhibition as a model predicting novel antipsychotics

E. Shadach, I. Weine, J. Feldon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 350 KB

english, 1999

33

Modeling sensory processing deficits of schizophrenia in laboratory animals

S. Leonard, K. Stevens, P. Bickford, L. Adler, R. Freedman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 168 KB

english, 1999

34

Bipolar temperaments and subthreshold bipolar disorders

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 341 KB

english, 1999

35

Specific characteristics of EPS — implications for drug development

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 357 KB

english, 1999

36

The relationship between parkinsonism, akathisla and tardive dyskinesia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 333 KB

english, 1999

37

Risk factors in development of movement disorders associated with neuroleptics

P.N. van Harten

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 308 KB

english, 1999

38

Atypical antipsychotics. Do they induce, mask or reduce tardive dyskinesia?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

39

Occurrence of EPS with atypical antipsychotics

J. Tauscher, B. Küfferle, C. Barnas, P. Fischer, S. Tauscher-Wismewski, S. Asenbaum, T. Brücke, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

40

The role of dopamine in drug addiction processes

M.A.F.M. Gerrits, J.M. van Ree

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

41

Modulation of drug-conditioned responses by NMDA receptor antagonists

E. Zvartau, A. Bespalov, O. Dravolina, P. Beardsley, R. Balster

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 340 KB

english, 1999

42

Brain opioid mechanisms in reward studied by PET

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 335 KB

english, 1999

43

Long-term effects of ecstasy use

R.J. Verkes, J.M.A. van Gerven, H.J. Gijsman, M.S.M. Pieters, A.F. Cohen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

44

Progress in pharmacotherapy of Alzheimer's disease: Symptomatic stabilization with cholinesterase inhibitors

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 324 KB

english, 1999

45

Therapy of Alzheimer's disease by the uncompetitive NMDA antagonist memantine

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

46

Neuronal nicotinic receptor agonists as potential therapeutic agents for Alzheimer's disease

K. Lloyd, F. Menzaghi, D. McClure, T. Gautille, S. Broome, T. Rao, C. Suto, J. McKelvy, V. Knott, P. Jordaan, J. Schneider, J. Buccafusco

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

47

Targeting serotonin/glutamate systems in Alzheimer's disease: Evidence from animal and human postmortem studies

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 348 KB

english, 1999

48

Ampakines: Treatment opportunity in Alzheimer's disease

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 345 KB

english, 1999

49

Neurobiology of social anxiety disorder

J.A. den Boer, F.J. Bosker, B.R. Slaap

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 343 KB

english, 1999

50

Gabapentin in social phobia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 175 KB

english, 1999

51

RIMA's and other drugs in social phobia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 338 KB

english, 1999

52

The place of drugs and cognitive behavior therapies in social phobia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

53

Suicide and attempted suicide in schizophrenia

H. Heilä, E. Isometsä, M. Henriksson, M. Heikkinen, M. Marttunen, J. Lönnqvist

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

54

Are atypical antipsychotics less depressogenic than typical compounds?

A.C. Altamura, A. Cao, M.L. La Croce, L. Serri, A. Soddu, A. Laddomada, M. Percudani

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 490 KB

english, 1999

55

Antidepressants and schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 163 KB

english, 1999

56

Prevention of suicide in depression and schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 163 KB

english, 1999

57

Opioids, single nucleotide polymorphisms, and addictions

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 310 KB

english, 1999

58

Animal models of addictive disorders

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 149 KB

english, 1999

59

Role of dopamine in drug reinforcement and addiction as revealed by imaging studies in humans

N. Volkow, J. Fowler

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 149 KB

english, 1999

60

The development of new medications for the treatment of alcoholism

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 327 KB

english, 1999

61

On treating addictions to smoked drugs

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 179 KB

english, 1999

62

Brain histamine in sleep-wake control

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 355 KB

english, 1999

63

Role of histamine in attention and learning disorders

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 178 KB

english, 1999

64

PET scan studies of histamine receptors in the human brain

K. Yanai, T. Watanabe, M. Itoh

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 351 KB

english, 1999

65

Potential role of histamine in schizophrenia

J.-M. Arrang, S. Morisset, C. Ito, J. Tardivel-Lacombe, M.-O. Krebs, J.-P. Olié, H. Lôo, M.-F. Poirier, E. Jönsson, G. Sedvall, M.-A. Crocq, P. Sokoloff, J.-C. Schwartz

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 344 KB

english, 1999

66

The burden and patterns of comorbidity of Generalized Anxiety Disorders

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 171 KB

english, 1999

67

The role of benzodiazepines and azapirones in the treatment of GAD

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 339 KB

english, 1999

68

Placebo-controlled evidence for the use of antidepressants in Generalized Anxiety Disorder

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 171 KB

english, 1999

69

Depression and generalised anxiety disorder: Separation evidence

D.J. Nutt, J.K. Abrams

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 302 KB

english, 1999

70

Neurobiological differences between responders and non-responders to SSRI treatments. Evidence from pindolol augmentation

F. Artigas, V. Pérez, E. Alvarez, I. Hervás, C. Queiroz, A. Adell, A. Raurich, R. Cortés

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 310 KB

english, 1999

71

Rapid response in antidepressant treatment

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 346 KB

english, 1999

72

Are some antidepressants more effective than others?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 171 KB

english, 1999

73

Interaction determines the choice of medication

P. Baumann, C.B. Eap, D. Zullino

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 171 KB

english, 1999

74

Chromosomal co-localization (CC) of retinoid receptors, apopotosis genes, schizophrenia candidate genes and schizophrenia genetic linkages suggest treatment strategies

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

75

Dopamine D3 receptor agents in schizophrenia

P. Sokoloff, J. Diaz, C. Pilon, J.-C. Schwartz

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 351 KB

english, 1999

76

D-cycloserine in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 362 KB

english, 1999

77

Glutamate receptor ligands in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 356 KB

english, 1999

78

Neurotrophins and neuronal plasticity

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 174 KB

english, 1999

79

BDNF knock-out mice fail to exhibit late-phase LTP

M. Korte, T. Bonhoeffer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 349 KB

english, 1999

80

Role of brain-derived neurotrophic factor in the control of D3 receptor expression

O. Guillin, L. Damier, N. Griffon, J. Diaz, P. Carroll, J.-C. Schwartz, P. Sokoloff

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 349 KB

english, 1999

81

Biological basis of OCD and OCD-related disorders

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

82

D8/17 B cell marker as a common biological marker in Tourette's syndrome, OCD and autism

E. Hollander, G. Delgiudice-Asch, C. Cartwright, C. DeCaria, C. Bienstock

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 342 KB

english, 1999

83

Comorbidity and spectrum disorders in childhood-onset OCD

M.F. Flament, D. Cohen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 171 KB

english, 1999

84

Long term management of obsessive-compulsive disorder

L. Ravizza, G. Maina, U. Albert, F. Bogetto

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 340 KB

english, 1999

85

Separating discontinuation symptoms from relapse

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 174 KB

english, 1999

86

Do antidepressants cause relapse?

S.A. Montgomery

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

87

Which antidepressant are effective and well tolerated in long term treatment?

P.H. Robert, M. Bernoit, E. Gokalsing, D. Pringuey

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

88

Psychological approaches or pharmacotherapy in long-term treatment of depression: The evidence

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 341 KB

english, 1999

89

How long to treat depression?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

90

Excitatory amino acid receptor antagonists as anti-ischemic agents in animal models of stroke

R. Gill, H.-P. Lorez, R. Wybrect, M.-T. Miss, M. Schmitt

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 346 KB

english, 1999

91

Primate models for studying functional recovery after drug treatment in stroke

J.W.B. Marshall, R.M. Ridley

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 345 KB

english, 1999

92

Clinical experience with the NMDA ion-channel blocker aptiganel hydrochloride (CNS 1102)

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 171 KB

english, 1999

93

Experimental and clinical experiences with clomethiazole, NXY-059 and AR-R15896

A.R. Green, T. Ashwood

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

94

Ligands for expression cloning and isolation of GABAB receptors

W. Fröstl, B. Bettler, H. Bittiger, J. Heid, K. Kaupmann, S.J. Mickel, D. Strub

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 328 KB

english, 1999

95

GABAB receptors are multimeric protein complexes

F.H. Marshall, J.H. White

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 331 KB

english, 1999

96

Distinct developmental regulation and cellular distribution of the GABAB-receptor GB1a and GB1b isoforms

J.-M. Fritschy, O. Giorgetta, D. Benke

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

97

Quantification of GABAB receptor mRNA in the CNS in rat models of neurological disease

D.C. Harrison, C.A. Campbell, B.C. Bond, R.P. Davis, A.A. Parsons, K.L. Philpott

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 171 KB

english, 1999

98

Complexities in the trauma response

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 346 KB

english, 1999

99

Methodological issues in PTSD research

J. Zohar, Y. Sasson, D. Amital, G. Cohen-Rappaport, M. Chopra, Y. Zinger

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 348 KB

english, 1999

100

Atypical neuroleptics in bipolar disorder

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 148 KB

english, 1999

101

New anti-epileptics as mood stabilisers

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 288 KB

english, 1999

102

Treatment of bipolar depression

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 144 KB

english, 1999

103

Prophylaxis of bipolar disorder

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 293 KB

english, 1999

104

Should schizophrenia be treated as a neurocognitive disorder?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 301 KB

english, 1999

105

Application of fMRI in studies on cognition

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 301 KB

english, 1999

106

Dementia in schizophrenia and the impact of atypical neuroleptics

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 146 KB

english, 1999

107

Roles of metabotropic glutamate receptors in synaptic plasticity

Z.A. Bortolotto, S.M. Fitzjohn, M.J. Palmer, Z.I. Bashir, G.L. Collingridge

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 294 KB

english, 1999

108

Functional roles of group I and group II metabotropic receptor subtypes

J.A. Kemp, F. Knoflach, J.N.C. Kew, G. Adam, T. Woltering, V. Mutel

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 151 KB

english, 1999

109

Development of metabotropic glutamate receptor subtype selective drugs

D.D. Schoepp, J. Cartmell, B.G. Johnson, R.A. Wright, S. Andis, C.R. Salhoff, J.P. Tizzano, P.L. Ornstein, J.A. Monn

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 218 KB

english, 1999

110

Double depression: Differential clinical characteristics and one-year follow-up

J. Usall, M. Marquez, M. Dolz

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

111

Comparing the onset of action of antidepressants: Comparison of different criteria applied to the same data set: Part II: Modification of criteria proposed in the literature

I.A. Niklson, P.-E. Reimitz

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 261 KB

english, 1999

112

Plasma noradrenaline and prediction of outcome in depressive illness

T. Johnston, C. Kelly, M. Stevenson, S.J. Cooper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 130 KB

english, 1999

113

Fluoxetine's efficacy in improving physical symptoms associated with PMDD

M. Steiner, S. Romano, S. Babcock

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 130 KB

english, 1999

114

Efficacy of fluoxetine in improving mood symptoms, physical symptoms, and social impairment in patients with PMDD

M. Steiner, S.J. Romano, S. Babcock, S. McCray, J.A. Dillon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 130 KB

english, 1999

115

Impact of premenstrual symptoms on functioning and treatment-seeking: Experience from the United States, United Kingdom, and France

T. Hylan, K. Sundell, R. Judge

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 134 KB

english, 1999

116

Long term treatment outcomes of highly anxious depressed patients: Evidence from a 52-week trial with fluoxetine

M. Schmidt, D. Michelson, C.M. Beasley Jr., J. Kopp, S. Koke

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 134 KB

english, 1999

117

Do antidepressants have antidepressant colours?

K. Schonauer, M. Klar, A. Erfurth

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 134 KB

english, 1999

118

The importance of the serotonergic system and substance P in fibromyalgia syndrome

M.J. Schwarz, B. Bondy, M. Späth, H. Müller-Bardorff, M. Offenbaecher, K. Glatzeder, M. Ackenheil

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

119

Efficacy and tolerability of gabapentin (GBP) and valproate (VPA) as an adjunct in the neuroleptic treatment of acute manic syndromes

G.G. Alberti, R. Garini, M. Marzolini, J. Beltz, M.I. Greco, G. Maresca

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

120

Fluoxetine efficacy and safety in depressed patients: A meta-analysis by gender

R.A. Judge, D.M. Millard, S.C. Koke, J.S. Gonzales

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 293 KB

english, 1999

121

Imidazoline receptors: Potential markers for depression and targets of antidepressant drag development

A. Halaris, J. Piletz

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 150 KB

english, 1999

122

Typology of chronic depression: A factor analysis approach

O. Živanović, Lj. Borišev, V. Borišev, V.R. Paunović

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 290 KB

english, 1999

123

Emergence of manic episodes in citalopram treated depressed patients

Y. Barak, R. Kimhi, R. Weizman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

124

Making valid inferences from claims data: A comparison of SSRI treatment costs

J.M. Russell, E.R. Berndt, R.J. Miceli, A.N. Grudzinski, S.V Colucci

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

125

Paroxetine in the treatment of depression with associated anxiety: A naturalistic study conducted in German private practice

R. Zaninelli, W. Meister

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 261 KB

english, 1999

126

The antidepressant effects of citalopram are mediated by the S-(+)- and not the R(−)-enantiomer

S. Hogg, C. Sánchez

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 120 KB

english, 1999

127

Light therapy is not effective in nonseasonal affective disorder

G.J. Schut, J. Dirkx, J.G. Goekoop, L. Timmerman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 120 KB

english, 1999

128

Schizoaffective psychoses: Differential features between Bipolar I disorder and schizophrenia

A. Benabarre, E. Vieta, F. Colom, A. Martínez-Arán, M. Reinares, C. Gastó

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

129

Characteristics and species generality of the antidepressant effect upon response duration differentiation

T.J. Hudzik, M. Yanek, M. Mastrangelo

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

130

Modulation of the serotonin transporter by the anti-inflammatory cytokine interleukin-4

R. Mössner, A. Heils, D. Albert, K.-P. Lesch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 282 KB

english, 1999

131

Buspiron and pindolol in augmentation therapy of treatment-resistant depression

A.S. Gönül, A. Oǧuz, İ. Yabanoǧlu, S.S. Aslan, T. Turan

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

132

Selective serotonin reuptake inhibitors: Discontinuation rates due to side effects

A.S. Gönül, I. Yabanoǧlu, M. Reyhancan, A. Oǧuz

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

133

Kidney functioning during short and long-term lithium treatment in bipolar patients

S. Sofuoǧlu, C. Utaş, S.S. Aslan, C. Yalçindaǧ, M. Baştürk, A.S. Gönül

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 281 KB

english, 1999

134

Serotonergic effects of protein-free diet in bipolar patients on long-term lithium treatment

M. Baştürk, Y. Özcan, E. Eşel, T. Turan, İ. Karaküçük, A.S. Gönül

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

135

Polarity of the first episode, clinical characteristics and course of 320 Bipolar I patients

G. Perugi, D. Madaro, C. Socci, G. Ruffolo, E. Bemi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

136

Gabapentin in treatment resistant bipolar mixed states

G. Perugi, C. Toni, G. Ruffolo, S. Sartini, F. Frare, L. Moretti

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 280 KB

english, 1999

137

Bipolar depressive mixed state in a clinical sample of 191 Bipolar I patients

G. Perugi, C. Socci, D. Madaro, F. Frare, C. Toni, B. Vitale

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

138

Citalopram is effective in obsessive compulsive disorder: Results of a double-blind, placebo-controlled trial

S. Kasper, I.D. Note, S. Montgomery

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 272 KB

english, 1999

139

Propofol and methohexital as anaesthetic agents for electroconvulsive therapy (ect): A comparison of seizure-quality measures, vital signs and therapeutic efficacy

C. Geretsegger, E. Rochowanski, P. Weihs, B. Judendorfer, W. Aichhorn, C. Sackel, C. Stuppaeck

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

140

Characteristics and treatment of a group of women with Premenstrual Dysphoric Disorder

D.G. Critchlow, A.J. Bond, J. Wingrove

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

141

Adenosine A1 and A2A receptors in serotonin transporter deficient mice

R. Mössner, D. Albert, A.M. Persico, B. Holtmann, D.L. Murphy, R. Simantov, J. Deckert, K.P. Lesch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 138 KB

english, 1999

142

Quality of life for patients with body dysmorphic disorder

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 138 KB

english, 1999

143

Patient categorisation of the severity of major depression agrees with clinician judgement

C.J. Hawley, T.M. Gale, T. Sivakumaran, J. Hayes, F. Hassan, A. Munns

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 138 KB

english, 1999

144

Oestrus cycle and the regional brain NPY concentrations in Flinders sensitive rats, an animal model of depression

P.A. Jiménez, F. Ghorbaninasab, D.H. Overstreet, A.A. Mathé

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 270 KB

english, 1999

145

PET neuroimaging shows antidepressant binding primarily at serotonin uptake sites in the dorsomedial thalamus of “higher” animals

D.F. Smith, A.D. Gee, E. Danielsen, K. Ishizu, M. Sakoh, J. Scheel-Krüger, A. Gjedde

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

146

Alpha-1-acid glycoprotein in major depressive disorder

E. Nieto, E. Vieta, L. Alvarez, M. Torra, F. Colom, C. Gastó

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

147

Gender differences in the prognosis of anxiety and depression — a follow-up study

I. Kecskés, E. Szádóczky, Z. Rihmer, J. Füredi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 271 KB

english, 1999

148

Open-label study of fluoxetine in civilian post-traumatic stress disorder

M. De Clercq, P.H. Hoyois, E. Vermeiren

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

149

Electroconvulsive therapy (ECT): Therapeutic efficacy and cognitive function

C. Geretsegger, B. Judendorfer, P. Weihs, W. Aichhorn, C. Sackel, C. Stuppaeck

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

150

Weight monitoring during two long-term trials of citalopram

A. Wade, K.F. Overø, O. Lemming

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 263 KB

english, 1999

151

Treatment of bipolar depression with topiramate

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 149 KB

english, 1999

152

Safety and pharmacokinetics of duloxetine, a potential new antidepressant with serotonin and norepinephrine uptake inhibition

L.-A. Granier, F. Vandenhende, J-M. de Suray, F. Grossman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 149 KB

english, 1999

153

Calcium homeostasis in lithium-treated patients with bipolar depression

A. El Khoury, A. Åberg-Wistedt, U. Pettersson, G. Kallner, R. Stain-Malmgren

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 137 KB

english, 1999

154

Open parallel 8-week study of sertraline versus imipramine in depressed outpatients without melancholia

E. Baca, M.Gonzalez de Chaves, M. Garcia-Toro, F. Perez-Arnau, A. Rivera, B. Penasa, S. Oliveros, M. Madrigal, J. Espejo, A. Porras, R. Lane

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 137 KB

english, 1999

155

Augmentation treatment by combination of high and low frequency rTMS in depression: Bilateral versus left hemispherical stimulation

A. Conca, P. König, W. Beraus, H. Schneider, A. Hausmann

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 137 KB

english, 1999

156

Venlafaxine versus fluoxetine in the treatment of depressed patients with concomitant anxiety

S. Geerts, P. Lacante, A. Mignon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 159 KB

english, 1999

157

Large, open-label study of venlafaxine in a naturalistic psychiatric setting

B. Gribomont, P. Lacante, A. Mignon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 159 KB

english, 1999

158

Response and remission with venlafaxine in hospitalized patients and outpatients with major depression. An open-label study in Belgium and Luxembourg

P. Lacante, A. Mignon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 323 KB

english, 1999

159

Melatonin response to atenolol administration in depression: Evidence for β-adrenoceptor up-regulation in a subtype of depression

T. Paparrigopoulos, C. Psarros, U. Dafni, J.D. Bergiannaki, E. Varsou

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

160

Different clinical characteristics between high and low melatonin excretors in depression

T. Paparrigopoulos, C. Psarros, U. Dafni, J.D. Bergiannaki, E. Varsou

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

161

Melatonin response to clonidine administration in depression: Further evidence for presynaptic α2-adrenoceptor supersensitivity

T. Paparrigopoulos, C. Psarros, J.D. Bergiannaki, E. Varsou, U. Dafni

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 337 KB

english, 1999

162

The role of olanzapine in dysphoric mania

A. González-Pinto, B. Lalaguna, F. Mosquera, J.L. Pérez de Heredia, B. Fernandez de Corres

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

163

Moclobemide and sleep

N. Stanley, I. Hindmarch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

164

Efficacy and tolerability of the hypericum special extract Ll 160 in young and elderly outpatients with depressive disorders: A drug monitoring study

E. Holsboer-Trachsler, S. Henauer, Ch. Vanoni

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 336 KB

english, 1999

165

Mood response and polysomnographic effects of a combined venlafaxine/trimipramine therapy in depressed patients with poor response to trimipramine monotherapy

U. Hemmeter, U. Brüderlin, M. Hatzinger, E. Holsboer-Trachsler

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

166

Improvement of cognitive function and sleep disturbances during treatment with extract of Ginkgo Biloba LI 1370 (GB): An open explorative pilot study in patients with major depression (MD)

M. Hatzinger, U. Hemmeter, B. Annen, E. Holsboer-Trachsler

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

167

Altered 5-HT2A binding sites and inositol triphosphate levels in hippocampus from depressed suicide victims

B. Arranz, P. Rosel, R. Cano, N. Ramirez, R. Dueñas, M.A. Navarro, L. San Benito Menni

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 320 KB

english, 1999

168

Switching to mirtazapine from SSRIs in everyday clinical practice: A naturalistic study in the Netherlands

J.A. Den Boer, A.J. Schutte, A.A.J. Boumans

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

169

Relationship between platelet-5-HT concentration and 5-HT uptake efficiency in healthy subjects and unmedicated patients with major depression

L. Franke, R. Uebelhack, B. Müller-Oerlinghausen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

170

Efficacy and tolerability of mirtazapine vs citalopram: A double-blind, randomized study in patients with major depressive disorder

H. Ågren, E. Leinonen, J. Skarstein, K. Behke, J.Th. Helsdingen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 319 KB

english, 1999

171

Tolerability of mirtazapine vs SSRIs in short term treatment of major depression

C.M.E. Kremer, J.T.H. Helsdingen, J.A. Schutte, E. Vester

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 163 KB

english, 1999

172

An open-label, naturalistic study of mirtazapine in Argentina

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 163 KB

english, 1999

173

Mirtazapine and ECT as combination therapy

B. Söderström

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 163 KB

english, 1999

174

Rapid onset of therapeutic action in major depression: A comparative trial of mirtazapine and paroxetine

O. Benkert, A. Szegedi, R. Kohnen, A.-J. Schutte

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 300 KB

english, 1999

175

Opioid involvement in antidepressant-type effect of NK3 receptor agonist, senktide, in the mouse forced swimming test

I. Panocka, M. Kowalczyk, B. Sadowski, I. Lapo, M. Masi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

176

An assessment of the potential for SSRI discontinuation syndrome with citalopram

J.S. Markowitz, C.L. DeVane

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

177

An open assessment of the safety and efficacy of venlafaxine in mild to moderate and in severe depression in usual care settings in Hungary

J. Demeter, M. Gyenis, K. Steel, A. Szabo

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 303 KB

english, 1999

178

An open assessment of the safety and efficacy of venlafaxine in mild to moderate and in severe depression in usual care settings in selected countries of eastern central Europe

J. Nowak, K. Steel

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

179

Do antidepressants have any potential to cause addiction?

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

180

The Lithium Side Effects Rating Scale (LISERS); development of a self-rating instrument

P. Haddad, A. Wieck, M. Yarrow, P. Denham

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 328 KB

english, 1999

181

Augmentation of antidepressant pharmacotherapy — a preclinical approach using the mouse forced swimming test

M. Bourin, M. Hascoët, M.C. Colombel, J.P. Redrobe

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

182

Citalopram vs. sertraline vs. placebo in the treatment of major depression

S.M. Stahl, C. Wilcox, K. Overo

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

183

Sexual dysfunction associated with the treatment of depression: A placebo-controlled comparison of bupropion sustained release and sertraline treatment

H. Croft, T. Houser, S.R. Batey, R.M.J. Donahue, J.A. Ascher

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 177 KB

english, 1999

184

Pretreatment anxiety does not predict response to bupropion sustained release or sertraline

A.J. Rush, S. Batey, R. Donahue, J.A. Ascher, T. Carmody

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 177 KB

english, 1999

185

Lamotrigine: Safety data from controlled monotherapy trials in depression

T. Suppes, L. Cunningham, T. Dinan, D. Grounds, P. Mitchell, K. Sokolski, S. West, J. Ascher, D. Babiar, J. Cedrone, A. Laurenza, E. Monaghan

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 177 KB

english, 1999

186

Predictors of response to sertraline in elderly major depression

P.M. Doraiswamy, S. Finkel, C.M. Clary

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 340 KB

english, 1999

187

True drug response versus placebo pattern response to fluoxetine: Differences in cognitive factors

S. Sonawalla, A. Farabaugh, V. Leslie, J. Alpert, A. Nierenberg, M. Fava

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

188

Sertraline and fluoxetine in depressed patients with psychomotor agitation

M. Flament, R.M. Lane

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 295 KB

english, 1999

189

A placebo-controlled study of sertraline in generalized social phobia

M. Van Ameringen, R. Swinson, J.R. Walked, R.M. Lane

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 154 KB

english, 1999

190

Does tryptophan depletion predict the future course of seasonal affective disorder/winter type (SAD)?

A. Neumeister, A. Habeler, N. Praschak-Rieder, M. Willeit, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 154 KB

english, 1999

191

Antidepressant therapy with mirtazapine under routine conditions. Results of a naturalistic study in 768 patients in Austria

A. Nimmerrichter, C. Simhandl

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 154 KB

english, 1999

192

Switching from SSRI to moclobemide (RIMA) without wash-out period

A. Németh, E. Vandlik

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

193

Fluvoxamine in combination with pindolol hastens the response of delusional depressives

R. Zanardi, L. Franchini, M. Gasperini, E. Smeraldi, J. Perez

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

194

A naturalistic study of mirtazapine in the Turkish psychiatric practice

A. Oǧuz, H. Saçli

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

195

Thyroid axis activity and serotonin function in major depressive episode

F. Duval, M.C. Mokrani, P. Bailey, T.S. Diep, M.A. Crocq, J.P. Macher

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 323 KB

english, 1999

196

Correlations between SPECT, contingent negative variation (event-related brain potentials), and major depression

A.F. Naviaux, V. Legrain, A. Pauwels, N. Zdanowicz, P. Janne, Ch. Reynaert

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 168 KB

english, 1999

197

An ultrashort depression self-rating instrument designed for repetitive use

J.F. Dreyfus, S. Charle, P. Auriche, J. Zeitoun

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 168 KB

english, 1999

198

Deviations in mood and personality in “Ecstasy” (3,4-methylenedioxymethamphetamine) users are not reflected in deviant cerebral blood flow: A [H215O]-Positron-Emission-Tomography study

A. Gamma, A. Buck, Th. Berthold, D. Hell, F.X. Vollenweider

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 331 KB

english, 1999

199

Incidence of depression in general practice and gynaecological practice in Belgium

K. van Heeringen, H. Boon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

200

Depression and ischaemic heart disease: Treatment considerations

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

201

Opposite effects of 3,4-methylenedioxy-methamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans

F.X. Vollenweider, M.E. Liechti, A. Gamma, M.A. Geyer, D. Hell

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 333 KB

english, 1999

202

Observational study of citalopram prescription in out-patients in France

J.C. Brosse, I. Perret, H.E.H. Petersen, P. Auquier, B. Begaud, P. Hardy, R. Sambuc, J.L. San Marco, M. Toumi, G. Houillon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

203

Tryptophan hydroxylase gene and affective disorder: An association study

G.N. Papadimitriou, E.G. Daskalopoulou, D.G. Dikeos, D. Avramopoulos, G. Karadima, C.N. Stefanis

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

204

Aniracetam treatment for lithium-produced cognitive deficits of bipolar patients

P.N. Malitas, B. Alevizos, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

205

Stimulation intensity and antidepressant action of repetitive transcranial magnetic stimulation

F. Padberg, P. Zwanzger, P. Mikhaiel, H. Thoma, H. Hampel, H.-J. Möller

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

206

A double-blind placebo-controlled investigation into the effects of tianeptine and mianserin on psychomotor performance and driving skills

F. Ridout, I. Hindmarch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

207

Serotonergic antidepressants' effects on vigilance and cognition

J. Schmitt, W. Riedel

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

208

Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation (rTMS): An open study

A. Erfurth, N. Michael, S. Nedjat, K. Schonauer, V. Arolt

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

209

Safety and efficacy of high dose venlafaxine added to electroconvulsive therapy (ECT) in therapy-resistant depression

N. Michael, C. Mostert, K. Schonauer, A. Erfurth

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

210

Effect of chronic administration of the selective glucocorticoid receptor antagonists ORG 34850, ORG 34116 and ORG 34517 on the rat hypothalamic-pituitary-adrenocortical axis

C.G. Bachmann, A.C.E. Linthorst, J.M.H.M. Reul

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

211

Differential modification of d-fenfluramine-induced serotonergic responses by acute and chronic sertraline and fluoxetine administration to rats

A. Harkin, M. Naughton, J.F. Cryan, J.P. Kelly, B.E. Leonard

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

212

Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat

T.J. Connor, P. Kelliher, A. Harkin, J.P. Kelly, B.E. Leonard

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

213

Social and economic depression and depressive disorders in the elderly

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 332 KB

english, 1999

214

Rapid remission of atypical depressive symptoms with the selective noradrenalin reuptake inhibitor reboxetine in SAD patients

E. Hilger, M. Willeit, N. Praschak-Rieder, A. Neumeister, J. Stastny, N. Thierry, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

215

Differential profile of opiates and tramadol on behavioral and biochemical tests predictive of antidepressant activity

J.A. Micó, M.O. Rojas-Corrales, A. Ortega-Alvaro, J. Gibert-Rahola

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 317 KB

english, 1999

216

Influence of lamotrigine on synaptic transmission, neuronal excitability and LTP in guinea pig hippocampal slices

J.M. Langosch, X.-Y. Zhou, M. Heinen, J. Walden

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 156 KB

english, 1999

217

A comparative analysis between venlafaxine and selective serotonin reuptake inhibitors (SSRIs) on remission for patients with major depressive disorder

R. Entsuah, R. Rudolph, E. Salinas

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 156 KB

english, 1999

218

A pooled-analysis comparing the efficacy of venlafaxine and selective serotonin reuptake inhibitors (SSRIs) in outpatients with major depressive disorder

R. Entsuah, R. Rudolph, D. Hackett

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 130 KB

english, 1999

219

Venlafaxine XR is superior to placebo in relapse prevention for patients with major depressive disorder

L. Aguiar, R. Entsuah, D. Lei, R. Rudolph

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 267 KB

english, 1999

220

[123I]-β-CIT SPECT shows lower midbrain serotonin transporter density in drug free depressed SAD patients

N. Praschak-Rieder, M. Willeit, A. Neumeister, W. Pirker, S. Asenbaum, E. Hilger, J. Stastny, T. Brücke, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 165 KB

english, 1999

221

Clinical characteristics of patients with recurrent brief depression (RBD)

L. Pezawas, M. Stamenkovic, S. Ackerl, C. Putz, B. Stelzer, T. Blasbichler, S. Schindler, H. Aschauer, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

222

Changes in health-related quality of life of patients with bipolar disorder treated with olanzapine

M. Namjoshi, T. Jacobs, T.M. Sanger, K.S. Gannon, M. Tohen, A. Breier

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 272 KB

english, 1999

223

Olanzapine in the treatment of rapid-cycling Bipolar I patients

T.M. Sanger, M. Tohen, T. Jacobs, K.S. Gannon, M. Greaney, V. Toma, G.D. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 133 KB

english, 1999

224

Olanzapine plus fluoxetine: Double-blind and open-label results in treatment-resistant major depressive disorder

M. Tohen, R. Shelton, G.D. Tollefson, S. Stahl, T. Jacobs, K.S. Gannon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 133 KB

english, 1999

225

Olanzapine versus haloperidol in schizoaffective disorder, bipolar type: A repeated measures analysis

F. Zhang, M. Tohen, T. Sanger, K.S. Gannon, G.D. Tollefson, A. Breier

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 274 KB

english, 1999

226

Olanzapine versus haloperidol: Assessment of cognitive function in patients with schizoaffective disorder, bipolar type

F. Zhang, M. Tohen, K.S. Gannon, A. Breier

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

227

Long-term olanzapine treatment: Efficacy and safety in manic patients with and without psychotic features

M. Tohen, T. Jacobs, K.S. Gannon, T.M. Sanger, M. Greaney, V. Toma, G.D. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

228

Olanzapine in the treatment of mania: A placebo-controlled four-week study

M. Tohen, T. Jacobs, V. Toma, J. Francis, F. Zhang, K.S. Gannon, T. Sanger, A. Breier

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

229

Frequency of sexual dysfunction in depressed adults and impact on quality of life

J.W.G. Tiller, M. Philipp, D. Baier, R. Kohnen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 159 KB

english, 1999

230

Comparison of moclobemide with selective serotonin reuptake inhibitors on sexual function in depression

M. Philipp, J.W.G. Tiller, D. Baier, R. Kohnen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 159 KB

english, 1999

231

Further characteristics of a new genetic mouse model of depression: Differential responsiveness of mice prone or resistant to helplessness in several behavioural tests

J.-M. Vaugeois, M. El Yacoubi, G. Passera, J. Costentin

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 312 KB

english, 1999

232

Selective adenosine A2A receptor antagonists are potential antidepressants: Evidence based on the activity of SCH 58261 and A2A knockout mice in screening procedures

M. El Yacoubi, C. Ledent, M. Parmentier, J. Costentin, J.-M. Vaugeois

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

233

Arginine vasopressin-neurophysin and DST in major depression: Relationship with suicidal behavior

W. Pitchot, M. Ansseau, J.-J. Legros

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

234

Open naturalistic study of adjunctive gabapentin in the treatment of bipolar spectrum disorder

M. Raja, A. Azzoni

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 331 KB

english, 1999

235

Lithium treated patients: Knowledge and attitude to lithium and their relationship to side-effects

A. Wieck, P. Haddad, P. Denham, M. Yarrow

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 180 KB

english, 1999

236

A multicenter, double-blind comparison of nefazodone and placebo in the treatment of panic disorder

G. Cassano, O. Benkert, A. Wade, U. Lepola, L. Bellodi, L. Skoglund, S. Ahrenstedt, M. Zibellini, A. Torbeyns, R. Marcus

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 180 KB

english, 1999

237

Altered sleep-endocrine regulation in depression — effect of GHRH

I.A. Antonijevic, H. Murck, R.-M. Frieboes, A. Steiger, F. Holsboer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 128 KB

english, 1999

238

Effects of sleep deprivation and recovery sleep after sleep deprivation on hormones in healthy subjects and drug-free depressive patients

U. Voderholzer, G. Weske, U. Fiedler, T. Klein, D. Riemann, F. Hohagen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 128 KB

english, 1999

239

Improvement of anxiety, depression and anhedonia under sertraline in a group of patients with major depression

P. Boyer, B. Falissart, S. Troy

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

240

The cortisol- and ACTH stimulation of reboxetine is blocked by mirtazapine in healthy subjects

C. Schüle, T. Baghai, G. Laakmann

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

241

Autopsies reveal decreasing antidepressant intoxications in Vienna between 1991 and 1997: The favourable consequence of the more frequent use of SSRIs

R. Frey, D. Schreinzer, T. Stimpfl, W. Vycudilik, A. Berzlanovich, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

242

Comorbidity does not modify the sleep of major depressed patients

X. Preud'homme, P. Titeca, P. Linkowski, J. Mendlewicz

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

243

Ginkgo Biloba relieves sexual dysfunction due to antidepressant drugs

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 330 KB

english, 1999

244

Correlations between cognitive and MRI characteristics in families of schizophrenics

V. Orlova, T. Savina, V. Trubnikov, N. Savvateeva, S. Odinsova, N. Shcherbakova

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 165 KB

english, 1999

245

Genetic determination of peculiarities of cognitive processes in the families of schizophrenics

T.D. Savina, V.A. Orlova, V.I. Trubnikov

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 165 KB

english, 1999

246

Determination of the optimal dose of risperidone in patients with schizophrenia

M. Çetin, S. Ebrinç, M.Y. Aǧargün, C. Başoglu, S. Yiǧit, V. Yilmaz, M. Seçil, N. Çobanoǧlu, S. Can

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 304 KB

english, 1999

247

HLA-A2 and B35 as strong predictors of responsiveness to clozapine in a sample of Italian schizophrenic patients

B. Grassi, M. Marchini, M. Epifani, R. Ferrari, R. Scorza, S. Scarone

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 144 KB

english, 1999

248

A shift to humoral immune response in schizophrenic patients

M.J. Schwarz, N. Müller, M. Riedel, M. Ackenheil

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 144 KB

english, 1999

249

Co-administration of Olanzapine with ECT

Y. Abramovitch, M. Weiser, F. Gelman, M. Assael

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 313 KB

english, 1999

250

Abnormal heart rate variability in clozapine treated patients

U. Loewenthal, H. Cohen, Z. Kaplan, M. Kotler

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

251

Clinical efficacy and safety of the sigma receptor ligand panamesine in schizophrenic patients

M.T. Huber, U. Gotthardt, W. Schreiber, J.-C. Krieg

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

252

Schizophrenia as initial manifestation in multiple sclerosis

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

253

Blockade of glucose transporters by antipsychotic drugs

D.S. Dwyer, R.J. Bradley, A.S. Kablinger, A.M. Freeman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 340 KB

english, 1999

254

Clinicians' awareness of cognitive dysfunction in schizophrenia: Findings from a European survey

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

255

Muscle biopsy, Macro EMG and clinical characteristics in patients with schizophrenia

L. Flyckt, J. Borg, K. Borg, T. Ansved, G. Edman, O. Sydow, L. Bjerkenstedt, F.-A. Wiesel

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

256

Clozapine treatment and post-traumatic psychotic disorders: A case report

A. Laddomada, M.L. La Croce, M.M. Paluello, L. Serri, A.C. Altamura

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 324 KB

english, 1999

257

Distress Scale for Adverse Symptoms: A new instrument for measuring the relationship between adverse drug symptoms and associated distress

M. Ritsner, I. Modai, O. Rivkin, E. Bystrov, J. Nehamkin, A. Ponizovsky

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

258

Selective impairment of sensory-perceptual functions in unaffected relatives of schizophrenic patients

S. Kéri, A. Antal, G. Benedek, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 317 KB

english, 1999

259

The atypical antipsychotic olanzapine does not induce Parkinson-like visuo-perceptual deficits

A. Antal, S. Kéri, G. Szekeres, G. Benedek, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

260

The effects of olanzapine, a novel atypical antipsychotic, on auditory p300 event-related potentials in schizophrenia

A.S. Gönül, C. Süer, A. Oǧuz, Ç. Özesmi, İ. Yabanoǧlu

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

261

Tc-99 HMPAO SPECT study of regional cerebral blood flow in drug-free and olanzapine-treated schizophrenic patients

A.S. Gönül, S. Sofuoǧlu, A. Tutus, M. Kula, M. Baştürk, E. Eşel, S.S. Aslan

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 277 KB

english, 1999

262

A retrospective and naturalistic review comparing outcomes of patients treated with olanzapine or risperidone

M. Snaterse, R. Welch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

263

S 18327, a novel phenylimidazolinone and potential antipsychotic: Antagonist properties at α2-adrenergic (AR) receptors in vitro and in vivo

M.J. Millan, F. Lejeune, A. Gobert, A. Newman-Tancredi, A. Adhumeau, J.-P. Nicolas, J.A. Boutin, J.-L. Peglion

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 316 KB

english, 1999

264

Advantaged receptor binding profile distinguishes BTS 79 018 from other antipsychotics

P.L. Needham, S.C. Cheetham, G. Gross

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 149 KB

english, 1999

265

Long-term treatment of chronic schizophrenia: Drug safety and relapse rate in risperidone

M. Philipp, M. Albus, A. Klauder, M. Linden

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 149 KB

english, 1999

266

Efficacy of risperidone on affective symptoms in acute schizophrenia

E. Rüther, A. Klauder

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 304 KB

english, 1999

267

Treatment habits with respect to risperidone in acute psychiatry in Germany

E. Rüther, A. Klauder

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

268

Platelet phospholipase A2 activity in schizophrenic and depressed patients

J.K. Rybakowski, P. Lewandowski, M. Krzystanek, E. Krzystanek, H.I. Trzeciak

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

269

Obsessive-compulsive disorder in first episode and chronic schizophrenic patients

M. Poyurovsky, V. Kris, G. Weisman, S. Hromnikov, V. Isakov, B. Rauchverger, I. Modai, M. Schneidman, A. Weizman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 324 KB

english, 1999

270

Short-term clinical efficacy and safety of clozapine in schizophrenia: A study with plasma levels

M.C. Mauri, V. Laini, L. Boscati, L. Mapelli, V. Ferrari, R. Orlandi, P. Papa

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

271

Average dose and weight: Olanzapine vs. risperidone

J.M. Russell, J.M. Martinez, J.A. Mackell, V. Mastey

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 268 KB

english, 1999

272

A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia

S. Hirsch, A. Power

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 126 KB

english, 1999

273

The impact of weight gain on quality of life among individuals with schizophrenia

D. Allison, J. Mackell

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 126 KB

english, 1999

274

Lack of drug interactions with ziprasidone: An overview

J. Miceli, T. Tensfeldt, C. Folger, K. Wilner

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 126 KB

english, 1999

275

Switching from conventional antipsychotics to ziprasidone: An interim analysis of a 6-week study

P. Weiden, G. Simpson, T. Kramer, P. Harvey

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 303 KB

english, 1999

276

Switching from risperidone to ziprasidone: An interim analysis of a 6-week study

G. Simpson, S. Potkin

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 153 KB

english, 1999

277

Improvement in markers of health status 6 weeks after switching from olanzapine to ziprasidone

D. Daniel, J. Lieberman, R. Birnbaum

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 153 KB

english, 1999

278

Switching from olanzapine to ziprasidone: An interim analysis of a 6-week study

D. Daniel, R. Stern, T. Kramer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 153 KB

english, 1999

279

Differing side effect burden with newer antipsychotics

P. Weiden, J. Mackell

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 127 KB

english, 1999

280

The link between drug attitudes, compliance behaviors, and resource use among individuals with schizophrenia

A.G. Awad, V. Mastey

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 127 KB

english, 1999

281

SB-269652 is a selective D3 receptor antagonist in vitro and in vivo

S.G. Taylor, G. Riley, A.J. Hunter, G. Stemp, C. Routledge, J.J. Hagan, C. Reavill

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 127 KB

english, 1999

282

Efficacy and tolerability of ‘Seroquel’ compared with haloperidol in schizophrenic patients partially responsive to conventional antipsychotic treatment

R.A. Emsley, J. Raniwalla, P. Bailey, A.M. Jones

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 192 KB

english, 1999

283

Quetiapine and risperidone in outpatients with psychotic disorders: Results of the QUEST trial

J. Mullen, M. Reinstein, M. Bari, L. Ginsberg, N. Sandler

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 192 KB

english, 1999

284

Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine in adolescents with selected psychotic disorders

B. McConville, L. Arvanitis, P. Thyrum, K. Smith

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 192 KB

english, 1999

285

Clinical Improvement and tolerability is maintained long term in elderly patients with psychotic disorders treated with quetiapine

P. Tariot, C. Salzman, P. Yeung, J. Pultz, J. Goldstein

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

286

Hippocampal deformities detected in schizophrenia and Alzheimer's disease by high dimensional brain mapping

J.G. Csernansky, L. Wang, S. Joshi, M. Gado, J. Morris, M.I. Miller

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

287

Risperidone vs haloperidol: Prevention of relapse in schizophrenia

J.G. Csernansky, A. Okamoto, M. Brecher

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 160 KB

english, 1999

288

RODOS: Studies in schizophrenia: Combined results

S. Kasper, I. Duchesne

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

289

Quality of life of schizophrenic patients treated with classic and “old” atypical neuroleptics

M. Jarema, Z. Konieczyńska

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

290

Olanzapine treatment of psychotic adolescents — change of body weight and adverse event profile

R.W. Dittmann, J. Junghanß

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 333 KB

english, 1999

291

Is there an association of response to haloperidol treatment with polymorphisms in the DRD2 or in the DRD3 receptor genes?

M. Schafer, D. Rujescu, A. Guntermann, I. Giegling, S. Dittert, H.-J. Möller, B. Bondy

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

292

Alterations of interneuronal subpopulations in rat hippocampus after chronic low dose exposition to a NMDA receptor antagonist; implications for schizophrenia

H. Grunze, A. Bender, S. Wendhof, R.W. Greene, H.-J. Möller, N. Müller, D. Rujescu

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

293

Extrapyramidal symptoms during haloperidol treatment are not associated with polymorphisms in the DRD2 and DRD3 receptor genes

D. Rujescu, M. Schäfer, A. Guntermann, I. Giegling, S. Dittert, H.-J. Möller, B. Bondy

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

294

Schizophrenia and seasonality of birth: Clinical features and biological patterns

A.C. Altamura, S. Bignotti, G.B. Tura, B. Brambilla, P. Mannu, M. Maes

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 178 KB

english, 1999

295

Suicidal behaviour in schizophrenia: A retrospective study

A.C. Altamura, S. Bignotti, R. Pioli, G. Rossi, G.B. Tura, P. Mannu, A. Soddu, L. la Croce

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 178 KB

english, 1999

296

Longitudinal changes of plasma HVA and 5-HIAA levels in schizophrenic patients resistant to neuroleptics

L.Bocchio Chiavetto, S. Bignotti, G.B. Tura, M. Maes, R. Pioli, C.A. Altamura, G. Racagni

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 348 KB

english, 1999

297

Effects of atypical antipsychotics on the inflammatory response system In schizophrenic patients resistant to treatment with haloperidol

M. Maes, L.Bocchio Chiavetto, S. Bignotti, G.B. Tura, F. Boin, G. Racagni, D. Van West, G. Kenis, E. Bosmans, C.A. Altamura

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 174 KB

english, 1999

298

The characteristics of the relationships between D2 receptor occupancy, antipsychotic effect and plasma prolactin

A.-L. Nordström, L. Farde

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 174 KB

english, 1999

299

The latent inhibition model discriminates between typical and atypical antipsychotics

E. Shadach, I. Gaisler, D. Schiller, J. Feldon, I. Weiner

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 277 KB

english, 1999

300

Subjective experiences of schizophrenic patients on atypical antipsychotic olanzapine and typical antipsychotic perphenazine

T. Szafránski, M. Jarema, M. Olajossy, W. Chrzanowski, A. Araszkiewicz, J. Landowski, J. Rybakowski, A. Bilikiewicz, J. Bomba

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 133 KB

english, 1999

301

Atypical neuroleptics, speed of processing and overall clinical psychopathology in schizophrenia

A. Politis, P. Oulis, I. Hatzimanolis, E. Balli, G.N. Christodoulou, C.N. Stefanis

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 133 KB

english, 1999

302

Apomorphine- and ketamine-induced disruption of prepulse inhibition of the acoustic startle reflex depend on temporal parametric conditions in rats

N. Canal, G. Sandner

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

303

Determinants of medication compliance in first-episode psychosis

O. Kampman, K. Lehtinen, J. Väänänen, E. Koivisto, P. Kiviniemi, N. Kilkku

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

304

Fluvoxamine-induced improvement in clozapine levels and clinical condition in clozapina-resistant schizophrenic patients

D. Baciu, E. Jaquenoud

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 271 KB

english, 1999

305

Quality of life: Superiority of amisulpride versus haloperidol: A 12-month study

L. Colonna, A. Giudicelli, D. Gérard

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 124 KB

english, 1999

306

Suicidal behaviour in amisulpride treated patients: A pooled review of 11 clinical studies

Y. Lecrubier, A. Giudicelli, C. Coulouvrat, E. Guérault, W. Rein

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 124 KB

english, 1999

307

Social adaptation in schizophrenic patients: Experience with amisulpride

A. Giudicelli, W. Rein

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 264 KB

english, 1999

308

Platelet serotonin S-HT2A binding sites and second messenger IP3 in schizophrenia

B. Arranz, P. Rosel, S. Sarró, B. Quetglas, P. Canut, J.M. Sanchez, R. Dueñas, L. San Benito Menni

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

309

Selective effects of haloperidol and lorazepam on the modulation of volitional saccadic eye movements

T. Crawford, L. Clark, J. Baxendale, J. Connell, J.F.W. Deakin

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

310

Drug and resource use evaluation of risperidone and olanzapine in inpatients with outpatient follow-up

D.M. Gardner, A.K. Woodman, L. Grasswick, L. Kopala

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 158 KB

english, 1999

311

Effects of risperidone on plasma homovanillic acid and prolactin in acute non-medicated schizophrenic patients

I. Baeza, J. Salvà, M. Bernardo, J. Gaya, J.M. Goikolea, M. Valdés

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 158 KB

english, 1999

312

The effect of risperidone on schizophrenic symptoms and eye movement disturbances

A. Borkowska, J.K. Rybakowski, A. Araszkiewicz, A. Rajewski, A. Kućma

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 158 KB

english, 1999

313

Altered antioxidant status in schizophrenic patients and the beneficial effect of treatment with vitamin E

P. Sirota, T. Mosheva, I. Reznik, T. Saks, A. Elizur, A. Hochman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

314

An economic evaluation of risperidone in chronic schizophrenia

P. Oh, K. Lanctôt, M. Iskedjian, A. Addis, N. Mittmann, T.R. Einarson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

315

Efficacy and safety of amisulpride versus haloperidol: A 4 month assessment

T. Lemperiere, D. Gérard, P. Raymondet, P. Carriere, M. Passamar, G. Ruetsch, R. Pandelon, A. Giudicelli

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 321 KB

english, 1999

316

Effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: Role of 5-HT2A and 5-HT2C receptor subtypes and significance of haloperidol dose used

G. Lucas, P. De Deurwaerdère, S. Caccia, U. Spampinato

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

317

Is high level of knowledge about schizophrenia associated to better patients' quality of life?

F. Rouillon, M. Ferreri, P. Nuss, N. Bazin, D. Gérard

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 340 KB

english, 1999

318

Coexistence of neuroleptic-induced movement side-effects: A comparative study

B.J. Havaki-Kontaxaki, V.P. Kontaxakis, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 178 KB

english, 1999

319

The effect of risperidone on aggression parameters in drug-naive first-episode schizophrenics

V. Kontaxakis, B. Havaki-Kontaxaki, S. Stamouli, E. Bali, N. Stefanis, G. Vaslamatzis, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 178 KB

english, 1999

320

Depressive symptoms in first-episode or relapsed acute schizophrenic inpatients

S. Stamouli, V Kontaxakis, B. Alevizos, B. Havaki-Kontaxaki, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 319 KB

english, 1999

321

HLA associations with clozapine-induced agranulocytosis/leukopenia in Greek schizophrenic patients

St. Theodoropoulou, K. Tarassi, C. Leotsakou, Th. Athanasiadis, J. Hatzimanolis, L. Lykouras, Chr. Papasteriades

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

322

Assessment of psychopathological and psychosocial adaptation of 145 schizophrenic patients

O. Canceil, D. Attar-Levy, M. Sampaio-Meireles, F. Guedj, M.C. Bourdel, M. Bouhassira, M.F. Poirier, J.P. Olie

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

323

A study of the quality of life of patients with schizophrenia treated in various mental health centers

F. Petitjean, F. Salome, C. Germain, J.C. Demant

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

324

Social phobia symptoms emerged during clozapine treatment: 4 case reports

S. Pallanti, L. Quercioli

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 146 KB

english, 1999

325

Treatment-emergent tardive dyskinesia in the long-term treatment of schizophrenia: A comparison of amisulpride and haloperidol

W. Rein, C. L'Héritier

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 146 KB

english, 1999

326

Iloperidone: A novel dopamine/serotonin antagonist with a unique preclinical profile

H.O. Kalkman, T. Matkovits-Gupta, L. Alphs, G. Gharabawi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 301 KB

english, 1999

327

Validity and factorial structure of a standardized examination for neurological soft-signs in schizophrenia

M.O. Krebs, A. Gut, M.C. Bourdel, J.P. Olie

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 159 KB

english, 1999

328

High dose famotidine in the treatment of refractory schizophrenia

P. Gotor, E.P. Calandre

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 159 KB

english, 1999

329

Clinical profile and other factors predicting the use of atypical antipsychotics

J. Cervilla, C. Pujol, M. Dolz, A. Fargas, C. Garcia-Ribera

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 159 KB

english, 1999

330

Prevalence and management of violence in two psychiatric intensive care units

M.Z. Dernovsek, V. Novak-Grubic, M. Rebolj, J. Resman, R. Tavcar, I. Unk, A. Zmitek

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

331

Prediction of treatment efficacy in first episode schizophrenia

E. Cesková, M. Lorenc, P. Drybcak, M. Ondrusová, P. Hrobar

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

332

Platelet intracellular calcium in response to glutamate: Selectivity of response in psychotic illnesses

M. Berk, H. Plein, B. Belsham

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 164 KB

english, 1999

333

Risperidone and olanzapin drug usage in a German hospital

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 277 KB

english, 1999

334

Risperidone Olanzapin Drug Outcomes study in Schizophrenia (RODOS) — first results of the German data

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

335

Extent of distress caused by adverse experiences associated with antipsychotic treatment

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

336

Is neuropeptide Y involved in the pathogenesis of disorders associated with hyperactivity of dopaminergic system?

A. Kask, J. Harro

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 327 KB

english, 1999

337

Cognitive subjective disturbances of schizophrenia: Effect of atypical neuroleptics

S. Pallanti, L. Quercioli

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

338

Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS) single-center report from 8an international study series

A. Bille, J. Andersen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

339

Computer-assisted self-monitoring by patients with schizophrenia

U. Gschwandtner, M. Koci, J. Hersberger, A. Riecher-Rössler

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 324 KB

english, 1999

340

Comparison of efficacy of clozapine, sulpiride, chlorpromazine and haloperidol in chronic schizophrenic patients therapy

B. Coşar, S. Candansayar, E. Taner, E. Işik

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

341

The influence of pernazine on EEG in schizophrenic patients

W. Jemajczyk, A. Wierzbicka, A.J. Wichniak, J. Antczak, E. Szatkowska, K. Czasak

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

342

Attitudes towards illness, antipsychotic medication and compliance in outpatients with schizophrenia

M. Rettenbacher-Oehl, M. Hummer, U. Eder, A. Hofer, G. Kemmler, I. Kurzthaler, E. Weiß, W.W. Fleischhacker

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

343

An open-label study of olanzapine in children with Pervasive Development Disorder

C. Kemner, H. van Engeland, H. Tuynman-Qua

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 333 KB

english, 1999

344

Olanzapine versus amisulpride and placebo in the treatment of negative symptoms and deficit states of chronic schizophrenia

Y. Lecrubier, M. Bouhassira, V. Olivier, S. Lancrenon, A.M. Crawford

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

345

Olanzapine versus clozapine in patients non-responsive or intolerant to standard acceptable treatment of schizophrenia

I. Bitter, S. Brook, M. Dossenbach, Z. Janka, Cs.M. Banki, S. Selemani, S. Grundy, F. Martenyi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

346

A cost-effectiveness clinical decision analysis for schizophrenia: Results from Sweden

I.-M. Wieselgren, E. Lindström, L. Lindström, L. Jönsson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

347

Olanzapine reduces levodopa-related dyskinesias in patients with Parkinson's disease

M. Canesi, A. Antonini, A. Colzi, D. Bravi, O. Pezzoli

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

348

Functional outcomes in schizophrenia: A European comparison of olanzapine and haloperidol

K.J. Gregor, S.H. Hamilton, E.T. Edgell

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

349

The cost-analysis of olanzapine compared with haloperidol and risperidone in the treatment of schizophrenia in the UK

S. Almond, O. O'Donnell, J. McKendrick

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 276 KB

english, 1999

350

Safety and effectiveness of olanzapine versus other antipsychotic drugs in the treatment of out-patients with schizophrenia

J.C. Gómez, J.A. Sacristán, P.R. Carrasco, C.A. Saiz, E.F. Carbonell

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

351

The effect of olanzapine on the psychopathologic clusters in patients refractory for clozapine treatment

F. Martényi, M. Dossenbach, S. Metcalfe, H. Belmaker, H. Munitz

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

352

The comparative anti-muscarinic-like side effect profiles of olanzapine and risperidone treatment in patients with schizophrenia spectrum psychosis

P.V. Tran, B.R. Basson, J.S. Kennedy, C.M. Beasley Jr., F.P. Bymaster, G.D. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 322 KB

english, 1999

353

Olanzapine compared to chlorpromazine in acute schizophrenia

N. Loza, A.M. El-Dosoky, T.A. Okasha, A.H. Khalil, N.M. Hasan, P. Kratky, A. Okasha

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 162 KB

english, 1999

354

Apples and apples, apples and oranges: The use and abuse of average dally dose in comparisons of atypical antipsychotic drug acquisition costs

P.J. Gibson, E.T. Edgell, D. Loosbrock, M. Kody, B. Dulisse

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 162 KB

english, 1999

355

Effect of chronic olanzapine treatment on the course of presumptive tardive dyskinesia

B.J. Kinon, D.R. Milton, V.L. Stauffer, B.R. Basson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 162 KB

english, 1999

356

Impact of olanzapine versus fluphenazine on patient's drug acceptance during acute treatment of schizophrenia

B. Schausberger, M. Dossenbach, L. Hotujac, V. Folnegovic-Smalc, B. Uglesic, M. Jakovljevic

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

357

Treatment of negative symptoms with olanzapine in comparison with other novel antipsychotic agents

S.R. David, K.M. Meehan, V.K. Sutton, C.C. Taylor

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

358

Effect of olanzapine on salivation is less prominent than predicted by its in vitro muscarinic binding profile

J. Czekalla, S. Bender, R.W. Dittmann, M. Gastpar

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 343 KB

english, 1999

359

Change in positive symptoms with olanzapine compared to other antipsychotic agents

K.M. Meehan, S.R. David, C.C. Taylor, V.K. Sutton

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

360

Evaluation of dry mouth and its treatment in the course of antipsychotic pharmacotherapy

S. Bender, J. Czekalla, S. Hille, T. Schlömer, A. Schlebusch, M. Gastpar

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

361

Cardiac safety profile of olanzapine based on preclinical and clinical ECG data

J. Czekalla, C.M. Beasley Jr., P.H. Berg

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 176 KB

english, 1999

362

Change in extrapyramidal symptoms with olanzapine in comparison with other antipsychotic agents

S.R. David, C.C. Taylor, K.M. Meehan

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 184 KB

english, 1999

363

Pharmacoeconomic evaluation of the treatment of schizophrenia in Germany: A comparison of olanzapine and haloperidol

A. Spainnheimer, J. Clouth

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 184 KB

english, 1999

364

Parvalbumin positive interneurons are selectively altered in number and function in rat hippocampus after chronic low dose exposure to MK 801

D. Rujescu, A. Bender, S. Wendhof, R. Greener, H.-J. Möller, N. Müller, H. Grunze

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 341 KB

english, 1999

365

Patients' awareness of sexual effects of psychotropic medication

M. Raja, A. Azzoni

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 162 KB

english, 1999

366

Schizophrenic psychopathology and presynaptic dopamine synthetic activity: A positron emission tomography study with [18F]fluorodopa

G. Gründer, E. Davids, N. Heydari, I. Vernaleken, P. Benz, R. Schlösser, J. Andreas, P. Stoeter, D.F. Wong, A. Gjedde

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 162 KB

english, 1999

367

Amygdala or ventral hippocampus lesions on day 7 of life in rat: An animal model of psychiatric neurodevelopmental disorders like schizophrenia

E.W.P.M. Daenen, G. Wolterink, M.A.F.M. Gerrits, C.G. Kruse, J.A.M. Van Der Heijden, J.M. Van Ree

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 319 KB

english, 1999

368

Comparative assessment of the positive and negative symptom dynamics in schizophrenic patients treated with atypical antipsychotics or haloperidol

S. Malyarov, G. Dzub

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

369

Polymorphisms in the APO E gene in gerontopsychiatric patients

P. Zill, B. Bondy, H. Hampel, F. Padberg, K. Buch, S. Stübner, T. Boetsch, M. Ackenheil

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

370

Speed/accuracy trade-off in patients with schizophrenia

M. Saoud, P. Dumas, T. d'Amato, J. Daléry, Y. Rossetti, T. Rochet

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

371

A comparison of long term outcome in first episode schizophrenia patients treated with risperidone or typical antipsychotics

A. Malla, R. Norman, S. Zirul, D. Scholten, V. Kotteda

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

372

Olanzapine in the treatment of paranoid schizophrenia

A.C. Altamura, I. Velonà, R. Curreli, D. Bravi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 335 KB

english, 1999

373

Central muscarinic cholinergic receptor availability in patients treated with clozapine

T.J. Raedler, M.B. Knable, R.A. Urbina, D.W. Jones, M.F. Egan, R. Coppola, D.R. Weinberger

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

374

Use of the Benzodiazepine Dependence Questionnaire as a predictor of the successful benzodiazepine discontinuation in patients with anxiety disorders

V. Starcevic, M. Latas, G. Bogojevic

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 172 KB

english, 1999

375

Efficacy of cognitive-behaviour therapy alone and cognitive-behaviour therapy combined with pharmacotherapy in the treatment of panic disorder with agoraphobia

V. Starcevic, E.H. Uhlenhuth, G. Bogojevic

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 322 KB

english, 1999

376

Premenstrual exacerbation and suicidal behavior in patients with panic disorder

M. Çetin, C. Başoǧlu, Ü.B. Semiz, M.Y. Aǧargün, S. Ebrinç

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 153 KB

english, 1999

377

Qualitative assessment of brain morphology in panic disorder

C. Wurthmann, J. Gregor, B. Bogerts

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 273 KB

english, 1999

378

Prefrontal enlargement of CSF spaces in agoraphobia: A qualitative CT-scan study

C. Wurthmann, J. Gregor, B. Bogerts

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

379

Cellular effects of the herbal anxiolytic and antiepileptic drug Aswal

H. Grunze, J. Walden

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

380

Chronic treatment with ipsapirone affects anxiety, but not depression in mice

D.F. Avgustinovich, O.V. Alekseyenko, L.A. Koryakina

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 151 KB

english, 1999

381

Effects of 3,4-methylenedioxymethamphetamine (“ecstasy”) on anxiety in light-dark aversion test in mice

E. Maldonado, J.F. Navarro, M. Cavas, C. Pedraza, D. Beltrán, G. Dávila

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 151 KB

english, 1999

382

Alprazolam retard in the treatment of pathological anxiety. Naturalistic study

J. de la Gándara, O. Sanz, A. Varona, P. Such

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 313 KB

english, 1999

383

Administration of high dose ketoconazole prevents anxiety-related behavior in an animal model of post-traumatic stress disorder

H. Cohen, J. Benjamin, Z. Kaplan, M. Kotler

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

384

Sensitivity to alprazolam effect in the staircase test in five inbred mouse strains

C.G. Pick, L. Paz, M.M. Backer, Z. Amiri, I. Modai, R. Weizman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

385

Influence of the serotonin antagonist, metergoline, on anxiogenic and neuroendocrine effects of carbon dioxide in healthy volunteers

G. Meiri, I.Z. Ben-Zion, B.D. Greenberg, D.L. Murphy, J. Benjamin

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

386

No association between joint hyperlaxity and panic disorder, nor between hyperlaxity and sensitivity to CO2 in healthy volunteers

J. Benjamin, I.Z. Ben-Zion, P. Dannon, S. Schreiber, G. Meiri, A. Ofek, A. Palatnik

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

387

The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration

S. Cheeta, P.J. Kenny, S.E. File

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

388

Neurochemical mechanisms by which dorsal hippocampal nicotinic acetylcholine receptors modulate anxiety

P.J. Kenny, S. Cheeta, A.-M. Ouagazzal, L.E. Gonzalez, S.E. File

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 166 KB

english, 1999

389

The changing faces of nicotine's effects on anxiety after acute and chronic administration

E. Irvine, S. Cheeta, S.E. File

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

390

Development of the contingent tolerance to midazolam in FR30 reinforcement schedule

H.B. Ayvaşik, S.C. Fowler, M.J. Kallman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

391

SSRIs revert the inhibitory effect of PKC on the 5-HT transporter in OCD

D. Marazziti, I. Masala, S. Baroni, A. Rossi, S. Presta, G. Giannaccini, L. Dell'Osso, A. Lucacchini, G.B. Cassano

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

392

Relationship between anxiety disorders and (hypo)mania

G. Perugi, C. Toni, F. Frare, B. Mata, B. Vitale

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 323 KB

english, 1999

393

Olanzapine added to fluoxetine in unresponsive obsessive-compulsive disorder

L. Koran, A. Ringold, M. Elliott

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 165 KB

english, 1999

394

Pharmacotherapy for OCD in a pre-paid health plan over time

L. Koran, J. Leventhal, B. Fireman, A. Jacobson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 165 KB

english, 1999

395

The assessment of relationship between mitral valve prolapse and panic disorder

L. Tamam, N. Özpoyraz, M. San, A. Bozkurt

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 174 KB

english, 1999

396

Topiramate in post-traumatic stress disorder — an open label study

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 336 KB

english, 1999

397

Fluvoxamine in childhood OCD: Long-term treatment

J. Walkup, E. Reeve, J. Yaruyura-Tobias, L. Wong, J. Claghorn, G. Gaffney, J. Greist, D. Holland, B. McConville, T. Pibott, M. Pravetz, L. Scahill, M. Riddle

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 168 KB

english, 1999

398

Life Events in high-dose and low-dose benzodiazepine users

N.P. Lekka, C. Paschalis, S. Beratis

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

399

The effect of the benzodiazepine receptor antagonist flumazenil on the anticonflict action of ACPC and CGP 37849 in rats

E. Tatarczyñska, E. Chojnacka-Wójcik, E. Przegaliñski

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 284 KB

english, 1999

400

The Mini-SPIN: A brief screening assessment for social phobia

K.M. Connor, K. Robak, L.E. Churchill, N.L.S. Potts, D. Katzelnick, J. Davidson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

401

Behavioural effects of rapid i.v. challenge with meta-chlorophenylpiperazine (0.1 mg/kg) in patients with panic disorder and controls

N. van der Wee, J. Fiselier, H. van Megen, I. Van Vliet, H. Westenberg

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 144 KB

english, 1999

402

Spatial working memory in obsessive compulsive disorder: A three-dimensional functional magnetic resonance imaging study

N. van der Wee, N. Ramsey, J. Jansma, H. van Megen, H. Westenberg, R. Kahn

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

403

Efficacy and safety of zolpidem 10 mg administered pro re nata (P.R.N) during 4 weeks in patients with chronic insomnia

L. Arbus, J. Lavoisy, J. Belin, C. Soubrane

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

404

The role of 5-HT2 receptors in experimentally induced anxiety

J. Connell, J.F.W. Deakin

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 280 KB

english, 1999

405

A CCKB receptor antagonist LY288513 reverses the anti-exploratory action of paroxetine, a selective serotonin reuptake inhibitor

M. Bourin, E. Vasar, S. Köks, V. Völkar

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

406

Influence of age on behavioural response in the light/dark paradigm

M. Bourin, M. Hascoët, M.C. Colombel

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

407

The influence of buspirone, and its major metabolite 1-PP, on the activity of paroxetine in the mouse-light-dark two compartments paradigm and four plates test

M. Bourin, M. Hascoët

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 288 KB

english, 1999

408

Anxiolytic-like activity of various antidepressants after acute administration, with the four plates paradigm in mice

M. Bourin, M. Hascoët, M.C. Colombel, A. Fiocco

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 149 KB

english, 1999

409

Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAA receptors

E. Davids, W. Hevers, K. Dämgen, H. Lüddens

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 282 KB

english, 1999

410

The efficacy of sertraline in panic disorder: Dose—response relationships

J. Sheikh, P. Londborg, C. Clary

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

411

Measuring treatment outcome in patients with social anxiety disorder

S.A. Montgomery

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

412

Response to paroxetine is maintained during continued treatment in patients with social anxiety disorder

R. Kumar, C. Pitts, D. Carpenter

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 262 KB

english, 1999

413

Paroxetine for social anxiety disorder: Review of three randomised, double-blind, placebo-controlled studies

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 128 KB

english, 1999

414

Disability associated with social anxiety disorder

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 128 KB

english, 1999

415

Effect sizes of rating scales in two multicenter trials of sertraline and placebo in posttraumatic stress disorder

J.R.T. Davidson, G.M. Farfel

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 260 KB

english, 1999

416

Panic attacks and avoidant personality disorder: Discriminating state and trait using the temperament and character inventory

G. Pérez, R. Martín-Santos, J. Sangorrín, F. Gutiérrez, M. Cabré, A. Bulbena

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 133 KB

english, 1999

417

Personality disorders predict non-response and delayed-response in combined drug and behavioural treatment of panic disorder

P. Berger, G. Sachs, M. Amering, D. Maierhofer, B. Bankier, H. Katschnig

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 133 KB

english, 1999

418

Significance of 5-HT2C- and 5-HT3-antagonism for the anxiolytic activity of cyamemazine

M. Alvarez-Guerra, F. d'Alché-Birée, F. Vargas, W.A. Wolf, M. Dib, R.P. Garay

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 271 KB

english, 1999

419

Conditional discrimination learning impairment — a panic disorder specific neuropsychological deficit

D. Maierhofer, K. Dantendorfer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 138 KB

english, 1999

420

Regional cerebral blood flow in patients with OCD and arachnophobia — a comparative f-MRI-study

M. Henke, L.Tebartz van Elst, B. Heßlinger, C. Janz, J. Hennig, D. Ebert

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 138 KB

english, 1999

421

Dose—response efficacy of long-term treatment of venlafaxine extended-release in generalized anxiety disorder

D. Hackett, A. Desmet, H.O. Salinas

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 138 KB

english, 1999

422

An assessment of the efficacy of venlafaxine extended-release in elderly patients with generalized anxiety disorder

V.J. Mahé, V. Haudiquet, D. Hackett, E.O. Salinas

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

423

Tolerabilty and effectiveness of citalopram and paroxetine treatments in panic patients

A. Bertani, G. Perna, D. Caldirola, R. Bussi, L. Bellodi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

424

Neuroanatomy of the panic-respiration system

G. Perna, A. Bertani, D. Caldirola, R. Bussi, L. Bellodi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 279 KB

english, 1999

425

Treatment results and personality disorders in social phobia

E. Pálová, M. Kovaničová

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 137 KB

english, 1999

426

The analysis of efficacy of different therapeutic strategies of borderline neuropsychic disorders

L.L. Pogorelova

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 137 KB

english, 1999

427

Anxiety symptoms analysis in patients with borderline disorders in therapy with cassadan

I.E. Kupriyanova

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 137 KB

english, 1999

428

Odors and thymic peptides as anxiolytics immunoprotectors

T. Nevidimova, N. Naidenova, I. Kupriyanova

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

429

Patterns of comorbidity between major depression, obsessive-compulsive disorder and panic disorder

A.C. Altamura, E. Mundo, M.Minio Paluello, P. Mannu

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

430

10 μg cholecystokinin tetrapeptide reduces the reaction to a 35% carbon dioxide challenge

K. Schruers, H. Pols, T. Overbeek, M. Bourin, E. Griez

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

431

Down's syndrome patients: Alzheimer-like implication of the immune system?

M.G. Carta, M.C. Hardoy, P.E. Manconi, P. Serra, A. Barranca, C.M. Caffarelli, E. Manca, A. Ghiani

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

432

A 72-week, placebo-controlled study assessing propentofylline's safety, efficacy, and impact on disease progression in patients with Alzheimer's disease

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

433

A 48-week, placebo-controlled study examining propentofylline's safety, efficacy, and impact on disease progression in patients with vascular dementia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 283 KB

english, 1999

434

Evaluation of AIT-082 in patients with mild to moderate senile dementia of the Alzheimer's type

S.D. Targum, S. Wieland, M.S. Glasky, A.J. Glasky

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

435

Using a combined randomized start/withdrawal design to assess propentofylline's effects on disease progression in Alzheimer's disease and vascular dementia: Results of clinical studies

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

436

Clinical characteristics in psychogeriatric patients with orthostatic hypotension and low blood pressure

A.K. Zacharof, C. Petrogiannopoulos, C. Flevaris, H. Zacharof

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 144 KB

english, 1999

437

Nociceptin/orphanin FQ modulates spatial learning via ORL1-receptors in rats

J. Sandin, S.O. Ögren, L. Terenius

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 144 KB

english, 1999

438

Atypical findings on magnetic resonance imaging in a cirrhotic patient: Improvement after orthotopic liver transplantation

A. Benabarre, P. Sort, J. Pujol, J. Ferrer, A. Martínez-Arán, F. Colom, M. Reinares, E. Vieta, C. Gastó

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 144 KB

english, 1999

439

Influence of hyperbaric oxygenation on the duration and intensity of psycho-organic disorders

N. Epifanova, M. Romasenko, I. Epifanov, A. Koukchina

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 136 KB

english, 1999

440

Preliminary study of apolipoprotein E allele frequency in Parkinson's disease and diffuse Lewy body disease

A. Juhász, R. Kárpáti, Gy. Dibó, J. Kálmán, Á. Rimanóczy, E. Csibri, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 136 KB

english, 1999

441

Dementia diagnosed by general practitioners: Applicability of recommendations and diagnostic accuracy

H.P.J. van Hout, M.J.F.J. Vernooij-Dassen, W.H.L. Hoefnagels, R.T.M. Grol

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 281 KB

english, 1999

442

Clinical symptoms of dementia with Lewy bodies: Secondary analyses of the Alzheimer's disease cooperative study selegiline and vitamin E clinical trial

J.T. Olin, M. Papka, S. Jin, M. Sano, M. Grundman, R. Thomas

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

443

Sertraline in the treatment of depression associated with Alzheimer disease

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

444

A long-term, double-blind, placebo-controlled efficacy and safety study of nicergoline in patients with mild to moderate Alzheimer's disease

L. Amaducci, K. Maurer, B. Winblad, R. Dom, R. Bullock, L. Bonura, A. Battaglia, B. Musch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 291 KB

english, 1999

445

Idiopathic vs symptomatic REM sleep behavior disorder: A report of two cases

T. Paparrigopoulos, T. Zabelis, A. Papageorgiou, C.R. Soldatos

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

446

Treatment with selegiline in Alzheimer's disease — SPECT evaluations

M.D. Gheorghe, G. Grigorescu

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

447

The effect of vinpocetine in vascular dementia

J. Leszek, A. Kiejna, K. Małyszczak

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 287 KB

english, 1999

448

Perinatal drug therapy: The risk of brain maldevelopment and adult neurobehavioural deviations in model experiments with rats

O. Benešová, H. Tejkalová, Z. Krištofiková, P. Hušek, J. Nedvídková, V. Panajotova

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

449

Apolipoprotein E genotype as a potential predictor of treatment outcome to acetycholin inhibitor Amiridin in patients with Alzheimer's disease

N. Selezneva, S. Gavrilova, E. Rogaev, G. Korovaitseva, T. Sherbatich, I. Kolykhalov, G. Jarikov

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 171 KB

english, 1999

450

Brain DC-potentials recording: Application to clinical pharmacology and clinical research

V.F. Fokin, N.V Ponomareva

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 339 KB

english, 1999

451

Neurophysiological predictors of clinical efficacy of acethylcholinesterase inhibitor amiridin in Alzheimer's disease

N.V. Ponomareva, N.D. Selesneva, O.V. Pendurina

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

452

Intracellular calcium level in blood platelets during normal and pathological aging and the effect of aluminofluoride complexes

D. Řipová, V. Platilová, R. Jirák, J. Obenberger, C. Höschl

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

453

Anticholinesterase treatment modulates cytokine network in Alzheimer's disease

P. Bongioanni, C. Bardi, M.R. Metelli, M. Tararà, D. Lucchesi, C. Chisari, G. Marcacci, B. Rossi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 332 KB

english, 1999

454

T-cell cytokine binding in myasthenia gravis

P. Bongioanni, R. Ricciardi, D. Lucchesi, B. Boccardi, S. Nuti, C. Baldini, C. Chisari, B. Rossi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 163 KB

english, 1999

455

Ondansetron, a 5-HT3 antagonist, improves tardive dyskinesia

P. Sirota, T. Mosheva, H. Shabtay, N. Giladi, A.D. Korcyn

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 163 KB

english, 1999

456

Donepezil in the treatment of Alzheimer's disease: Results from the first year of a study in clinical practice in the UK

H.P. Matthews, J. Korbey, D.G. Wilkinson, J. Rowden

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 333 KB

english, 1999

457

Anticholinesterases in the treatment of Alzheimer's disease — the first year's experience in Argyll & Clyde

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

458

Donepezil preserves functional status in Alzheimer's disease patients: Results from a 1-year prospective placebo-controlled attrition study

R. Mohs, R. Doody, J. Morris, J.R. Ieni, S.L. Rogers, C.A. Perdomo, R.D. Pratt

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 173 KB

english, 1999

459

Safety of donepezil in extended treatment of Alzheimer's disease

J.R. Ieni, C.A. Perdomo, R.D. Pratt

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 352 KB

english, 1999

460

Alfa-2-adrenoreceptor antagonism and serotonin reuptake inhibition in patients with Parkinson's disease and depression

D. Aarsland, J.P. Larsen, N.G. Lim, L. Wermuth, P. Bech

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

461

Neuroendocrinological and polysomnographical investigations in OCD and Tourette Syndrome

M. Riedel, N. Kathmann, A. Straube, N. Müller

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

462

Effect of valproic acid on serum lipoproteins and apolipoproteins in epileptic children

A. Vilchez, E.P. Calandre, P. García-Saura, M. Gerónimo, C.M. Rodriguez, M.D. Cano

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 346 KB

english, 1999

463

Clinical implications of neuroSPECT findings and neuropsychological evaluation in the treatment of minor traumatic brain injury

E. Goshen, T. Gur-Hartman, E. Klag, Y. Gross, C.G. Pick, S.T. Zwas, S. Schreiber

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

464

Long term effect of minor traumatic brain injury on mice performance in the Morris water maze

C.G. Pick, V. Getslev, S. Schreiber

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 168 KB

english, 1999

465

Neuropsychological assessment of modification of efficacy of cholinergic therapy by preceding cerebrolysin treatment in Alzheimer's disease

I. Rochtchina, S. Gavrilova, I. Kolykchalov, N. Selezneva, G. Jarikov

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 168 KB

english, 1999

466

Clinical efficacy of exelon in patients with Alzheimer's disease

S. Gavrilova, I. Kolykhalov, N. Selezneva, Ya. Kalyn, G. Jarikov, N. Mikhailova, A. Bratsoun

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 334 KB

english, 1999

467

Intermittent explosive disorder in patients with temporal lobe epilepsy — a quantitative magnetic resonance imaging study of the amygdala

L.Tebartz van Elst, F.G. Woermann, L. Lemieux, P. Thompson, M.R. Trimble

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

468

Olanzapine reduces psychosis and behavioral disturbances associated with Alzheimer's disease

J. Street, W.S. Clark, K.S. Gannon, S. Mitan, D. Kadam, T. Sanger, R. Tamura, G.D. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 170 KB

english, 1999

469

Reduction of psychotic symptoms in patients with Lewy Body-like symptoms treated with olanzapine

J. Street, W.S. Clark, K.S. Gannon, T. Sanger, A. Breier

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 343 KB

english, 1999

470

Olanzapine in the prevention of psychosis among nursing home patients with behavioral disturbances associated with Aizheimer's disease

W.S. Clark, J. Street, K.S. Gaimon, T. Sanger, G.D. Tollefson, A. Breier

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 148 KB

english, 1999

471

Beneficial effect of Donepezil on tardive dyskinesia in a schizophrenic patient with Aizheimer's disease

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 148 KB

english, 1999

472

Role of the Shaker-like Kv1.1 potassium channel in mouse cognitive processes

C. Ghelardini, N. Galeotti, A. Bartolini

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 283 KB

english, 1999

473

A possible biological role of dopaminergic system in drug abuse

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

474

New treatment for the withdrawal at drug addiction

P. Gaszner, I. Csernus

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

475

5-HT1A receptors and amphetamine sensitization in mice

E. Przegaliński, J. Siwanowicz, L. Baran, M. Filip

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 261 KB

english, 1999

476

Cognitive performance in chronic alcoholic patients according to ACE genetic polymorphism

D. Bartrés-Faz, I. Clemente, M. Monràs, M. Muñoz, T. López, T. Valveny, P. Moral, A. Gual, M. Sánchez-Turet, C. Junqué

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 151 KB

english, 1999

477

Use of MDMA (“Ecstasy”) and Its homologues among German university freshmen

K. Schonauer, W. Blass, A. Erfurth

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 313 KB

english, 1999

478

Some clinico—biochemical aspects of hyperbaric oxygenation effect in the treatment of opium poisoning

N. Epifanova, M. Romaseno, A. Koukchina, I. Epifanov

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

479

The persistence of anxious symptoms after a usage of illegal drugs

I. Kecskés, Z. Rihmer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 167 KB

english, 1999

480

Effects of chronic ethanol ingestion on dopamine and serotonin metabolism in the rat brain

İ.T. Uzbay, S.E. Usanmaz, E.S. Akarsu

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 321 KB

english, 1999

481

Novelty seeking predicts relapse in detoxified male alcohol dependents

H.N. Aschauer, K. Meszaros, E. Lenzinger, K. Hornik, T. Füreder, V. Willinger, G. Fischer, G. Schönbeck

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 133 KB

english, 1999

482

Effect of acamprosate on the hypothalamic-pituitary-adrenal (HRA) system in early abstinent alcoholics

U. Zimmermann, W. Hundt, A. Grabner, K. Hahn, F. Holsboer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 133 KB

english, 1999

483

Craving for alcohol during alcohol withdrawal seems to be related to elevated leptin plasma levels

F. Kiefer, H. Jahn, M. Kellner, D. Naber, K. Wiedemann

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

484

Comparison of psychological coping mechanisms between alcoholics, depressives and control subjects

T. Paparrigopoulos, J. Liappas, I. Tzavellas, A. Gouzaris, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

485

Psychiatric Research Interview for Substance and Mental disorders (PRISM): Validation of the Spanish version

D. Serrano, G. Pérez, A. Ortells, R. Martin-Santos, C. Castillo, M. Torrens

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 157 KB

english, 1999

486

Effectiveness of gabapentin on the substance-oriented behaviors of alcohol-dependent detoxified outpatients

L. Janiri, A. Hadjichristos, G. Pozzi, D. Costantino, R. Pecora, S. De Risio

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 324 KB

english, 1999

487

Gabapentin in drug/alcohol dependent Inpatients with comorbid psychiatric disorders and subsequent follow-up study

M. Parisi, L. Janiri, S. Rullo, S. Fontana, A. Petiziol, S. De Risio

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

488

Impaired cognitive performance in drag-free recreational ecstasy (MDMA) users raises concern about neurotoxic brain damage

E. Gouzoulis-Mayfrank, J. Daumann, F. Tuchtenhagen, B. Fimm, H. Sass

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 275 KB

english, 1999

489

Benzodiazepine preferences among patients in methadone maintenance treatment (MMT)

M. Pàmias, C. Castillo, H. Manteca, M. Segura, R. De la Torre, M. Torrens

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

490

Buprenorphine versus methadone maintenance for the treatment of opioid dependence

H. Eder, G. Fischer, W. Gombas, R. Jagsch, A. Peternell, G. Stühlinger, H.N. Aschauer, S. Rasper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

491

Diversification in opioid maintenance therapy for pregnant women

A. Peternell, G. Fischer, H. Eder, K. Rohrmeister, R. Jagsch, M. Langer, H.N. Aschauer, M. Weninger

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 271 KB

english, 1999

492

Open-label maintenance study with buprenorphine in pregnant opiate addicts

G. Fischer, H. Eder, R. Jagsch, A. Peternell, M. Weninger, M. Langer, H.N. Aschauer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

493

Licit and illicit substance use among delinquent and non-delinquent alcoholics: Preliminary report

J. Liappas, E. Peppas, T. Paparrigopoulos, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

494

Attitudes of users, ex-users and professional workers about drug addiction phenomenon

J. Liappas, E. Mellos, P. Papavasiliou, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 278 KB

english, 1999

495

Reduction of benzodiazepine use by letter in primary care: First results of the Benzoredux-study stage I

R.C. Oude Voshaar, W. Gorgels, A.J.J. Mol, M.H.M. Breteler, E. van de Lisdonk, A.J.L.M. van Balkom, F.G. Zitman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

496

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) are attenuated by the serotonin uptake inhibitor citalopram

M.E. Liechti, Ch. Baumann, D. Hell, F.X. Vollenweider

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 271 KB

english, 1999

497

Drug-addiction and criminal activity. A preventive treatment with methadone?

E. Resinger, M. Kopeinig, G. Knecht, J. Scharfetter, M. Neider, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

498

High dosage buprenorphine in primary care. A preliminary survey

J. Beauvillain, P. Petit, I. Grailles, A.H. Pho, J. Catteau, P. Chevalier, P. Beauvillain, G. Legal

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

499

Does the success of maintenance depend on the gp's methods and his personal commitment to substitution?

I. Grailles, A.H. Pho, J. Catteau, C. Loiseau, J.Y. Forestier, P. Petit, J. Beauvillain, P. Beauvillain, G. Legal, P.J. Parquet

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

500

Addictive-anxiety disorders comorbidity: Role of childhood separation anxiety disorder

I. Bailly-Lambin, D. Bailly

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

501

Immunotoxicokinetic of MDMA in mice

R. Pacifici, S. Di Carlo, A. Bacosi, P. Zuccaro

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

502

Heroin and morphine metabolism in mice

P. Zuccaro, S. Pichini, R. Pacifici

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 278 KB

english, 1999

503

A 6 months follow up of 30 patients with alcohol dependence and acamprosate treatment

A. Chinchilla, M. Vega, A. Cebollada

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 136 KB

english, 1999

504

Prevalence and relapse predicting value of Cloninger's alcoholism types

E. Lenzinger, K. Meszaros, U. Willinger, G. Fischer, G. Schönbeck, K. Hornik, H.N. Aschauer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 136 KB

english, 1999

505

Treatment of bulimia nervosa with acamprosate. A case reports preliminary study

J. Martínez-Raga, J. Treasure, U. Schmidt, P. Webster

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 136 KB

english, 1999

506

The use of antagonists in treating opiate withdrawal

P. Mannelli, A. Buonanno, S. De Risio

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

507

Neuropsychological profile and DRD2-TAQ1 allele distribution in alcoholic subjects in remission

M. Wolff, C. Blas, F. Paez, S. Deeds, H. Nicolini

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

508

Effects of nitric oxide synthase inhibitors NG-nitro-L-argInine and 7-nitroindazole on behavioural signs of ethanol withdrawal

P. Pokk, V. Vassiljev, M. Väli, A. Zharkovsky

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 276 KB

english, 1999

509

Excess TPH 17 779C allele in surviving cotwins of monozygotic twin suicide victims

A. Roy, G. Rylander, M. Asberg, C. Mazzanti, D. Goldman, D. Nielsen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

510

Gerontopsychiatric networking in rural areas

W. Schreiber, Th. Schneyer, R. Schlichting, T. Becker, J.-C. Krieg

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

511

Iontophoretic study of dopamine and its antagonists on motor cortical neuron activity elicited by stimulation of ventrolateral nucleus of the cat

K. Huda, K. Matsunami, T.L. Salunga, X.E. Han, S.A. Chowdhury

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 280 KB

english, 1999

512

Nimodipine attenuates psychotigenic effects of ketamine in humans

E. Krupitsky, A. Burakov, T. Romanova, S. Vegso, J. Krystal

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

513

Effects of N-nitro-L-arginine, a nitric oxide synthase inhibitor, on Ag-NOR activity in striatum of mice

C. Pedraza, J.F. Navarro, L.J. Santín, J.L. Arias

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

514

Absence of tolerance to cataleptic activity of gamma-hydroxybutyric acid after subchronic administration to male mice

C. Pedraza, J.F. Navarro, E. Maldonado, M. Cavas

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 281 KB

english, 1999

515

Gammahydroxybutyrate-induced catalepsy is potentiated by N-nitro-L-arginine administration in female mice

M. Cavas, C. Pedraza, E. Maldonado, G. Dávila, J.F. Navarro

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

516

C-fos mRNA expression in rate hippocampal neurons by haloperidol, imipramine and amitriptyline

E.G. Park, B.H. Yang, E.K. Chai, Y.G. Cho

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

517

Interaction of M- and N-cholinergic mechanisms and parkinsonism

B.I. Tkachenko, N.A. Losev, L.N. Shalkovskaya

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 287 KB

english, 1999

518

Phosphorylation of chromosomal HMG proteins: Neuropharmacological aspects

N.S. Sapronov, B.A. Reikhardt, O.O. Kulikova

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

519

A comparison of dexamethasone suppression test and TRH test findings in psychiatric patients and normal controls

B. Taneli, K. Yazici, M. Sertel, A. Ertekin, S. Taneli, S. Kirli

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

520

Rapid activation of extracellular signal-regulated kinase by estrogen in vivo

Y. Kuroki, Y. Kanda, K. Mizuno, Y. Watanabe

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 287 KB

english, 1999

521

Association between DRD3 gene and novelty seeking in bipolar patients

A. Heiden, F. Leisch, J. Scharfetter, L. Nilsson, M. Willeit, C. Gebhardt, K. Fuchs, W. Sieghart, S. Kasper, H.N. Aschauer

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

522

Is benzodiazepine-induced amnesia due to deactivation of the left prefrontal cortex?

E. Fluck, M. Bagary, S.E. File, E. Joyce, G. Lockwood, P. Grasby

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

523

Is affective sensitisation clinically relevant? A novel life charting model for evaluating illness progression in recurrent affective disorders

A. Ehnvall, H. Ågren

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 282 KB

english, 1999

524

Different monoaminergic substrates for outward-directed and self-destructive violent behaviour

H. Sőderström, A. Forsman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

525

New approaches to overcoming of therapeutic resistance of neuroleptic extrapyramidal disorders (the experience of “magne B6” use)

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 276 KB

english, 1999

526

Pharmacological characterization of the serotonin transporter in young and elderly subjects

D. Marazziti, S. Baroni, A. Rossi, I. Masala, G. Giannaccini, A. Lucacchini, G.B. Cassano

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 138 KB

english, 1999

527

Inverse agonists and constitutive S-HT1B receptor activation by a series of mutations in its BBXXB motif

P.J. Pauwels, T. Wurch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 138 KB

english, 1999

528

A neuropharmacological study of Lisanul Asafir (seeds of Wrightia tinctoria, Br.) — a Unani herbal drug

M.A. Jafri, K.M.Y. Amin

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 283 KB

english, 1999

529

Inositol treatment on bulimia nervosa and binge eating: A controlled study

D. Gelber, J. Levine, R.H. Belmaker

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

530

Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene in Israeli sibling pairs

Y. Osher, D. Hamer, J. Benjamin

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

531

National study of the management of puerperal disorders within Mother and Baby Units

A.G. Roberts, B. Battacharya

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 287 KB

english, 1999

532

Changes In extracellular noradrenaline induced by conditioned environmental stimuli: A microdialysis study in the freely-moving rat

R. McQuade, S.C. Stanford

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 141 KB

english, 1999

533

Towards a more rational use of psychoactive substances in clinical practice

D.M.H. Van Hyfte, P.P. de Vries^Robbé, T.B. Tjandra-Maga, A.A. Van Der Maas, F.G. Zitman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 284 KB

english, 1999

534

Gabapentin in psychiatric patients committed to prison

A. Pacileo, A. Piro

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

535

Spatial visualization and relative quantification of D2- dopamine receptors in a human post mortem brain hemisphere

S. Pauli, H. Hall, C. Halldin, Y.L. Hurd, G. Sedvall

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 143 KB

english, 1999

536

The effects of donepezil on nicotinic and muscarinic blockade in healthy humans: A functional brain electrical imaging study

J.C. Thompson, P.J. Nathan, C. Stough, D. Ames, C. Ritchie, R.B. Silberstein

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 287 KB

english, 1999

537

Changes to prefrontal electrophysiological activity during enhanced attention following nicotine

J.C. Thompson, K. Tzambazis, C. Stough, A. Pipingas, P. Nathan, R.B. Silberstein

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

538

Alcohol impairs speed of information processing, simple and choice reaction time and differentially impairs higher order cognitive abilities

K. Tzambazis, C. Stough

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

539

The role of the neurotransmitter Acetylcholine in Inspection Time

C. Stough, T.C. Bates, P. Nathan, J. Thompson

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 275 KB

english, 1999

540

Preliminary, open-label study of topiramate in rapid cycling bipolar women

V. Kusumakar, L. Yatham, S. Kutcher, C. O'Donovan

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

541

No clinically significant effect of topiramate on haloperidol plasma concentration

D.R. Doose, K.A. Kohl, D. Desai-Krieger, J. Natarajan, D.P. van Kammen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

542

Topiramate in the treatment of refractory bipolar mood disorder

G. Sachs, M. Sambur, C. Demopulous, S. Ghaemi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 264 KB

english, 1999

543

Topiramate as adjunctive treatment in bipolar disorder

K.N.R. Chengappa, D. Rathore, J. Levine, R. Atzert, L. Solai, H. Parepally

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 134 KB

english, 1999

544

Development of a model to estimate the clinical and economic impact of mood stabilizer treatment for Bipolar I disorder

L. Bryant-Comstock, P.E. Keck Jr., D.B. Mather, E. Bell, S.D. Sullivan

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 134 KB

english, 1999

545

Risperidone in children with conduct disorder

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 261 KB

english, 1999

546

Seasonal influence on platelet serotonin function in healthy volunteers

J. Neuger, A. Åberg-Wistedt, R. Stain-Malmgren

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 129 KB

english, 1999

547

Low-dose pergolide in the treatment of tardive dyskinesia (TD): A double-blind, placebo-controlled randomized cross-over trial

A. Diehl, H.P. Hundemer, M. Rubin, R.W. Dittmann, W. Gattaz

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 129 KB

english, 1999

548

HIV and psychiatric disorders in general hospital

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 129 KB

english, 1999

549

Self-harming behavior and serotonin: A genetic association study

A. Rotondo, A. Lunardi, A. Armani, C. Gonnelli, L. Tiano, L. Pardini, S. Bouanani, A. Bandettini, I. Masala, M.C. Mazzanti, D. Goldman, G.B. Cassano, L. Dell'Osso

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

550

The effects of zaleplon at the time of peak plasma concentration versus zolpidem and triazolam

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

551

The effects of age and gender on the pharmacokinetics of zaleplon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

552

The safety of long-term treatment of insomnia with zaleplon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 269 KB

english, 1999

553

The relationship between the pharmacokinetics and pharmacodynamics of zaleplon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

554

Zaleplon is effective in reducing time to sleep onset

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

555

Zaleplon provides safe long-term treatment of insomnia in the elderly

J. Hedner, R. Mangano

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

556

Effects of risperidone on the schedule-induced polydipsia in rats

G.C. Lee, J.H. Lee, H.K. Jeong, T.S. Kim, D.J. Yoon

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

557

Suicidal behaviour associated with substance abuse

J. Irurita, M. Irurita, J. Larrache, P. Betancor, P. Saavedra

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 288 KB

english, 1999

558

The measurement of daytime ‘sleep-like’ activity using actigraphs

N. Stanley, J. Dawson, I. Hindmarch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

559

An Investigation into the effects of ebastine on cognitive function and psychomotor performance following acute and repeated doses in healthy volunteers

Z. Shamsi, I. Hindmarch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 147 KB

english, 1999

560

Interleukin-6 activates STAT- and MAPK-signal transduction pathways and induces de novo-protein synthesis in human neuronal cells

G. Schumann, M. Huell, U Machein, G. Hocke, B.L. Fiebich

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 285 KB

english, 1999

561

The influence of MAO inhibitors on cognitive functions in rats

E. Nowakowska, A. Chodera, K. Kus, P. Richter

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

562

Yohimbine hydrochloride in erectile dysfunction: Action on symptomatology, sleep, and nocturnal penile tumescence (NPT)

M.H. Wiegand, H.J. Vogt, G. Kockott, Z. Veselý, M. Gierend

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

563

Concomitant use of mirtazapine and risperidone: A pilot study

C.H. Doorschot, A.J.M. Loonen, M.C.J.M. Oostelbos, J. Huisman, J.M.A. Sitsen

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 278 KB

english, 1999

564

Mirtazapine in the treatment of irritable bowel syndrome: A pilot study

L. Tanum, N. Moe

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

565

Impulsive aggression is associated with lifetime history of suicide attempt. Towards a description of patients with serotonergic dysfunction

M. Schäfer, D. Rujescu, I. Giegling, G. Scheerer, A. Gietl, A. Ebner, R. Engel, H.-J. Möller

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

566

P300 amplitude is associated with genetic variations in the DRD3 dopamine receptor gene

D. Rujescu, I. Giegling, A. Riehle, G. Juckel, P. Mavrogiorgou, G. Scheerer, D. Müller, R. Engel, H.-J. Möller, U. Hegerl

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

567

Psychiatric aspects of therapy with corticosteroids in asthma

F. Çam Çelikel, Ö. Saatçioǧlu, S. Çelikel, S. Türkcan, M. Yaman

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 267 KB

english, 1999

568

Effect of acute tryptophan depletion on negative priming

J. Wingrove, A.J. Bond, D.G. Critchlow

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 128 KB

english, 1999

569

A randomized double-blind placebo-controlled study of bupropion sustained release in obesity

K. Gadde, K.R.R. Krishnan

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 128 KB

english, 1999

570

Reboxetine for treatment of bulimia nervosa (BN): First results

U. Bailer, M. de Zwaan, N. El-Giamal, C. Lennkh, A. Strnad, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 128 KB

english, 1999

571

Sertraline and quality of life across mood and anxiety disorders

J. Endicott, M. Rapaport, C. Clary

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

572

Behavioural effects of the aqueous extract of Gluera senegalensis in mice and rats

S. Amos, K. Gamaniel, E. Kolawole, P. Akah, C. Wambebe

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

573

Effect of St. John's wort on cytochrome (CYP) P-450 activity in healthy volunteers

J.S. Markowitz, C.L. DeVane, S.W. Carson, Z. Nahas, D.W. Boulton, K. Chike-Harris, J.W.W. Leung, S.C. Risch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 279 KB

english, 1999

574

Validity and utility of the cognitive drug research (CDR) computerised cognitive testing system: A review following fifteen years of usage

K.A. Wesnes, T. Ward, G. Ayre, C. Pincock

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

575

Development and validation of a system for evaluating cognitive functioning over the telephone for use in late phase drug development

K.A. Wesnes, T. Ward, G. Ayre, C. Pincock

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 139 KB

english, 1999

576

The effects of acute doses of standardised Ginkgo Biloba Extract on memory and psychomotor performance in healthy volunteers

U. Rigney, I. Hindmarch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 281 KB

english, 1999

577

Double-blind evaluation of vitamin B6 vs placebo in treatment of tardive dyskinesia

V Lerner, Ch. Miodownik, A. Kaptsan, H. Cohen, V. Loewental, M. Kotler

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 144 KB

english, 1999

578

An investigation of the pharmacokinetic profile of Loprazolam in 12 young and 12 elderly healthy volunteers

M. Dorling, I. Hindmarch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 144 KB

english, 1999

579

An investigation into the effects of cetirizine and loratadine on cognitive function and psychomotor performance

Z. Shamsi, S. Kimber, I. Hindmarch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 291 KB

english, 1999

580

Vitamin status and cognitive functioning in healthy, elderly volunteers

S.M. Cockle, J. Haller, S. Kimber, I. Hindmarch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 148 KB

english, 1999

581

Study observing multicultural attitudes to sulpiride in the treatment of somatoform disorders

F. Rouillon, J. Gonzalez Dunia

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 148 KB

english, 1999

582

Effects of a herbal medicine, Huangqin, on central dopaminergic system

W.Y. Chang, S.R. Chang, J.F. Liao

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 289 KB

english, 1999

583

Sleep polygraphy: A tool for diagnosis in pseudo depressive dementia. Improving the visual scoring method with digital periodic analysis

F.-S. Kohl, D. Pringuey, F. Cherikh, J.L. Belugou, C. Cherrey

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

584

Efforts to make psychiatric diagnosing simple: The CIDI-SF of the World Health Organization

G. Tacchini, S. Charitos, G. Penati, O. Fusi, J. Sironi

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 142 KB

english, 1999

585

The antinociceptive effect of venlafaxine in mice is mediated by both opioid and adrenergic systems

S. Schreiber, M.M. Backer, C.G. Pick

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 276 KB

english, 1999

586

Cross-sectional comorbid mental pathology in the late life major depression

A. Medvedev, M. Belova, A. Kolesnitshenko, A. Kurmishev, P. Tshebishev, T. Shishina, E. Sheveleva

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 137 KB

english, 1999

587

1H Spectroscopy in borderline patients

M. Henke, T. Thiel, L.Tebartz van Elst, J. Hennig, D. Ebert

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 137 KB

english, 1999

588

Lifetime aggression in patients with a history of suicide attempts. Is there an association with a polymorphism in the promotor of the 5-HT2A serotonin receptor gene?

D. Rujescu, M. Schäfer, I. Giegling, G. Scheerer, A. Gietl, A. Ebner, R. Engel, H.-J. Möller

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

589

Influence of age and sex on hippocampal local inhibitory circuitry

D. Rujescu, S. Wendhof, A. Bender, R.W. Greene, H.-J. Möller, N. Müuller, H. Grunze

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

590

Fluoxetine vs. cognitive behavioral therapy in relapse prevention for anorexia nervosa

K. Halmi, J. Mitchell, S. Crow

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 135 KB

english, 1999

591

Pet imaging of D2-like dopamine receptors in the human brain with [18F]desmethoxyfallypride

G. Gründer, M. Piel, R. Schirrmacher, W. Hamkens, U. Schmitt, P. Benz, C. Hiemke, F. Rösch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 247 KB

english, 1999

592

Positron emission tomography of benzodiazepine receptors in the human brain with [18F]fluoroethylflumazenil

G. Gründer, W. Hamkens, M. Piel, R. Schirrmacher, U. Schmitt, R. Kleinz, P. Benz, H. Lüddens, F. Rösch

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 115 KB

english, 1999

593

Effect of [Hyp6]-dermorphin on spontaneous behaviour and thermoregulation in rats

A.P. Bonartsev, M.G. Uranova, T.G. Emel'yanova, A.B. Usenko, A.A. Kamensky, L.A. Andreeva, L.Y. Alfeeva

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 115 KB

english, 1999

594

Chronically administrated in early postnatal period β-casomorphin-7 evoked prolonged changes in albino rat behaviour

I.V. Malinovskaia, V.A. Dubinin, Yu.A. Ivleva, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 93 KB

english, 1999

595

Body dysmorphic disorder: Diagnostic spectrum and comorbidity patterns

A.C. Altamura, E. Mundo, S. Medda, P. Mannu

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 93 KB

english, 1999

596

Author index

Journal:

European Neuropsychopharmacology

Year:

1999

File:

PDF, 1012 KB

1999

597

Subject index

Journal:

European Neuropsychopharmacology

Year:

1999

Language:

english

File:

PDF, 440 KB

english, 1999